Knowledge

Genome editing

Source 📝

572:(NHEJ), resulting in gene disruptions through the introduction of small insertions or deletions. Each repeat is conserved, with the exception of the so-called repeat variable di-residues (RVDs) at amino acid positions 12 and 13. The RVDs determine the DNA sequence to which the TALE will bind. This simple one-to-one correspondence between the TALE repeats and the corresponding DNA sequence makes the process of assembling repeat arrays to recognize novel DNA sequences straightforward. These TALEs can be fused to the catalytic domain from a DNA nuclease, FokI, to generate a transcription activator-like effector nuclease (TALEN). The resultant TALEN constructs combine specificity and activity, effectively generating engineered sequence-specific nucleases that bind and cleave DNA sequences only at pre-selected sites. The TALEN target recognition system is based on an easy-to-predict code. TAL nucleases are specific to their target due in part to the length of their 30+ base pairs binding site. TALEN can be performed within a 6 base pairs range of any single nucleotide in the entire genome. 518:. Each finger of the Zinc finger domain is completely independent and the binding capacity of one finger is impacted by its neighbor. TALEs on the other hand are found in repeats with a one-to-one recognition ratio between the amino acids and the recognized nucleotide pairs. Because both zinc fingers and TALEs happen in repeated patterns, different combinations can be tried to create a wide variety of sequence specificities. Zinc fingers have been more established in these terms and approaches such as modular assembly (where Zinc fingers correlated with a triplet sequence are attached in a row to cover the required sequence), OPEN (low-stringency selection of peptide domains vs. triplet nucleotides followed by high-stringency selections of peptide combination vs. the final target in bacterial systems), and bacterial one-hybrid screening of zinc finger libraries among other methods have been used to make site specific nucleases. 673:) followed by outgrowth, during which bacteriophage homologous recombination proteins mediate annealing of ssDNAs to their genomic targets. Experiments targeting selective phenotypic markers are screened and identified by plating the cells on differential medias. Each cycle ultimately takes 2.5 hours to process, with additional time required to grow isogenic cultures and characterize mutations. By iteratively introducing libraries of mutagenic ssDNAs targeting multiple sites, MAGE can generate combinatorial genetic diversity in a cell population. There can be up to 50 genome edits, from single nucleotide base pairs to whole genome or gene networks simultaneously with results in a matter of days. 353: 657: 1365:" – to perform their own experiments, posing a potential risk from the release of genetically modified bugs. The review also found that the risks and benefits of modifying a person's genome – and having those changes pass on to future generations – are so complex that they demand urgent ethical scrutiny. Such modifications might have unintended consequences which could harm not only the child, but also their future children, as the altered gene would be in their sperm or eggs. In 2001 Australian researchers Ronald Jackson and Ian Ramshaw were criticized for publishing a paper in the 559:(TALENs) are specific DNA-binding proteins that feature an array of 33 or 34-amino acid repeats. TALENs are artificial restriction enzymes designed by fusing the DNA cutting domain of a nuclease to TALE domains, which can be tailored to specifically recognize a unique DNA sequence. These fusion proteins serve as readily targetable "DNA scissors" for gene editing applications that enable to perform targeted genome modifications such as sequence insertion, deletion, repair and replacement in living cells. The DNA binding domains, which can be designed to bind any desired DNA sequence, comes from 20: 1354:, stating that genome editing conducted by countries with regulatory or ethical standards "different from Western countries" probably increases the risk of the creation of harmful biological agents or products. According to the statement the broad distribution, low cost, and accelerated pace of development of this technology, its deliberate or unintentional misuse might lead to far-reaching economic and national security implications. For instance technologies such as CRISPR could be used to make "killer mosquitoes" that cause plagues that wipe out staple crops. 665:
observe the phenotype, and start the process over with a different single-gene manipulation. Therefore, researchers at the Wyss Institute at Harvard University designed the MAGE, a powerful technology that improves the process of in vivo genome editing. It allows for quick and efficient manipulations of a genome, all happening in a machine small enough to put on top of a small kitchen table. Those mutations combine with the variation that naturally occurs during cell mitosis creating billions of cellular mutations.
809: 640:
cheapest method, only costing less than two hundred dollars and a few days of time. CRISPR also requires the least amount of expertise in molecular biology as the design lays in the guide RNA instead of the proteins. One major advantage that CRISPR has over the ZFN and TALEN methods is that it can be directed to target different DNA sequences using its ~80nt CRISPR sgRNAs, while both ZFN and TALEN methods required construction and testing of the proteins created for targeting each DNA sequence.
820:, ZFNs, and TALEN provides a new strategy for genetic manipulation in plants and are likely to assist in the engineering of desired plant traits by modifying endogenous genes. For instance, site-specific gene addition in major crop species can be used for 'trait stacking' whereby several desired traits are physically linked to ensure their co-segregation during the breeding processes. Progress in such cases have been recently reported in 393: 506:
combinations that offer the best specificity and the best cell tolerance. Although the direct genome-wide characterization of zinc finger nuclease activity has not been reported, an assay that measures the total number of double-strand DNA breaks in cells found that only one to two such breaks occur above background in cells treated with zinc finger nucleases with a 24 bp composite recognition site and obligate heterodimer
473:
to find an endonuclease whose DNA recognition site and cleaving site were separate from each other, a situation that is not the most common among restriction enzymes. Once this enzyme was found, its cleaving portion could be separated which would be very non-specific as it would have no recognition ability. This portion could then be linked to sequence recognizing peptides that could lead to very high specificity.
549: 213:-compliant regulation to rules closer to those of the US and some other countries. An April 2021 European Commission report found "strong indications" that the current regulatory regime was not appropriate for gene editing. Later in 2021, researchers announced a CRISPR alternative, labeled obligate mobile element–guided activity (OMEGA) proteins including IscB, IsrB and TnpB as endonucleases found in 514:
recognition peptide. ZFNs rely on Cys2-His2 zinc fingers and TALEN constructs on TALEs. Both of these DNA recognizing peptide domains have the characteristic that they are naturally found in combinations in their proteins. Cys2-His2 Zinc fingers typically happen in repeats that are 3 bp apart and are found in diverse combinations in a variety of nucleic acid interacting proteins such as
800:
expression analysis has resolved a transcriptional road-map of human development from which key candidate genes are being identified for functional studies. Using global transcriptomics data to guide experimentation, the CRISPR based genome editing tool has made it feasible to disrupt or remove key genes in order to elucidate function in a human setting.
486:. The zinc ion, found in 8% of all human proteins, plays an important role in the organization of their three-dimensional structure. In transcription factors, it is most often located at the protein-DNA interaction sites, where it stabilizes the motif. The C-terminal part of each finger is responsible for the specific recognition of the DNA sequence. 3231: 836:(PAT) into the targeted endogenous locus IPK1 in this case. Such genome modification observed in the regenerated plants has been shown to be inheritable and was transmitted to the next generation. A potentially successful example of the application of genome editing techniques in crop improvement can be found in banana, where scientists used 832:, using ZFN-assisted gene targeting, two herbicide-resistant genes (tobacco acetolactate synthase SuRA and SuRB) were introduced to SuR loci with as high as 2% transformed cells with mutations. In Zea mays, disruption of the target locus was achieved by ZFN-induced DSBs and the resulting NHEJ. ZFN was also used to drive herbicide-tolerance 335:, it is possible to knock out or switch on genes only in certain cells. These techniques were also used to remove marker genes from transgenic animals. Further modifications of these systems allowed researchers to induce recombination only under certain conditions, allowing genes to be knocked out or expressed at desired times or 1257:
system, the programmed Cas9 protein and the sgRNA can be directly introduced into fertilized zygotes to achieve the desired gene modifications when creating transgenic models in rodents. This allows bypassing of the usual cell targeting stage in generating transgenic lines, and as a result, it reduces generation time by 90%.
490:
gene. It has been demonstrated that this strategy can be used to promote a process of angiogenesis in animals. It is also possible to fuse a protein constructed in this way with the catalytic domain of an endonuclease in order to induce a targeted DNA break, and therefore to use these proteins as genome engineering tools.
705: 725:
ZFN-mediated mutants and the improvements in TALEN-based approaches testify to the significance of the methods, and the list is expanding rapidly. Genome editing with engineered nucleases will likely contribute to many fields of life sciences from studying gene functions in plants and animals to gene
472:
As opposed to meganucleases, the concept behind ZFNs and TALEN technology is based on a non-specific DNA cutting catalytic domain, which can then be linked to specific DNA sequence recognizing peptides such as zinc fingers and transcription activator-like effectors (TALEs). The first step to this was
448:
methods have been used to create meganuclease variants that recognize unique sequences. Others have been able to fuse various meganucleases and create hybrid enzymes that recognize a new sequence. Yet others have attempted to alter the DNA interacting aminoacids of the meganuclease to design sequence
1252:
Although GEEN has higher efficiency than many other methods in reverse genetics, it is still not highly efficient; in many cases less than half of the treated populations obtain the desired changes. For example, when one is planning to use the cell's NHEJ to create a mutation, the cell's HDR systems
1245:
Because of the ease of use and cost-efficiency of CRISPR, extensive research is currently being done on it. There are now more publications on CRISPR than ZFN and TALEN despite how recent the discovery of CRISPR is. Both CRISPR and TALEN are favored to be the choices to be implemented in large-scale
788:
Furthermore, gene editing can be applied to certain types of fish in aquaculture such as Atlantic salmon. Gene editing in fish is currently experimental, but the possibilities include growth, disease resistance, sterility, controlled reproduction, and colour. Selecting for these traits can allow for
676:
MAGE experiments can be divided into three classes, characterized by varying degrees of scale and complexity: (i) many target sites, single genetic mutations; (ii) single target site, many genetic mutations; and (iii) many target sites, many genetic mutations. An example of class three was reflected
631:
Meganucleases method of gene editing is the least efficient of the methods mentioned above. Due to the nature of its DNA-binding element and the cleaving element, it is limited to recognizing one potential target every 1,000 nucleotides. ZFN was developed to overcome the limitations of meganuclease.
505:
Several approaches are used to design specific zinc finger nucleases for the chosen sequences. The most widespread involves combining zinc-finger units with known specificities (modular assembly). Various selection techniques, using bacteria, yeast or mammal cells have been developed to identify the
489:
The recognized sequences are short, made up of around 3 base pairs, but by combining 6 to 8 zinc fingers whose recognition sites have been characterized, it is possible to obtain specific proteins for sequences of around 20 base pairs. It is therefore possible to control the expression of a specific
400:
The key to genome editing is creating a DSB at a specific point within the genome. Commonly used restriction enzymes are effective at cutting DNA, but generally recognize and cut at multiple sites. To overcome this challenge and create site-specific DSB, three distinct classes of nucleases have been
330:
is an enzyme that removes DNA by homologous recombination between binding sequences known as Lox-P sites. The Flip-FRT system operates in a similar way, with the Flip recombinase recognising FRT sequences. By crossing an organism containing the recombinase sites flanking the gene of interest with an
1233:
In the future, an important goal of research into genome editing with engineered nucleases must be the improvement of the safety and specificity of the nucleases action. For example, improving the ability to detect off-target events can improve our ability to learn about ways of preventing them. In
1260:
One potential that CRISPR brings with its effectiveness is the application of xenotransplantation. In previous research trials, CRISPR demonstrated the ability to target and eliminate endogenous retroviruses, which reduces the risk of transmitting diseases and reduces immune barriers. Eliminating
1241:
into modifying the genome with engineered nucleases has shown the need for better understanding of the basic recombination and repair machinery of DNA. In the future, a possible method to identify secondary targets would be to capture broken ends from cells expressing the ZFNs and to sequence the
1103:
practice is that which replaces the defective gene with a normal allele at its natural location. This is advantageous over a virally delivered gene as there is no need to include the full coding sequences and regulatory sequences when only a small proportions of the gene needs to be altered as is
854:
Several optimizations need to be made in order to improve editing plant genomes using ZFN-mediated targeting. There is a need for reliable design and subsequent test of the nucleases, the absence of toxicity of the nucleases, the appropriate choice of the plant tissue for targeting, the routes of
439:
Meganucleases, found commonly in microbial species, have the unique property of having very long recognition sequences (>14bp) thus making them naturally very specific. However, there is virtually no chance of finding the exact meganuclease required to act on a chosen specific DNA sequence. To
1256:
Traditionally, mice have been the most common choice for researchers as a host of a disease model. CRISPR can help bridge the gap between this model and human clinical trials by creating transgenic disease models in larger animals such as pigs, dogs, and non-human primates. Using the CRISPR-Cas9
664:
The methods for scientists and researchers wanting to study genomic diversity and all possible associated phenotypes were very slow, expensive, and inefficient. Prior to this new revolution, researchers would have to do single-gene manipulations and tweak the genome one little section at a time,
647:
of an active nuclease would have potentially dangerous consequences at the genetic and organismal levels, the precision of meganucleases, ZFNs, CRISPR, and TALEN-based fusions has been an active area of research. While variable figures have been reported, ZFNs tend to have more cytotoxicity than
635:
TALE nucleases being the most precise and specific method yields a higher efficiency than the previous two methods. It achieves such efficiency because the DNA-binding element consists of an array of TALE subunits, each of them having the capability of recognizing a specific DNA nucleotide chain
695:
to overproduce isoprenoid lycopene. It took them about 3 days and just over $ 1,000 in materials. The ease, speed, and cost efficiency in which MAGE can alter genomes can transform how industries approach the manufacturing and production of important compounds in the bioengineering, bioenergy,
632:
The number of possible targets ZFN can recognized was increased to one in every 140 nucleotides. However, both methods are unpredictable because of their DNA-binding elements affecting each other. As a result, high degrees of expertise and lengthy and costly validations processes are required.
613:
One of the earliest methods of efficiently editing nucleic acids employs nucleobase modifying enzymes directed by nucleic acid guide sequences was first described in the 1990s and has seen resurgence more recently. This method has the advantage that it does not require breaking the genomic DNA
513:
The heterodimer functioning nucleases would avoid the possibility of unwanted homodimer activity and thus increase specificity of the DSB. Although the nuclease portions of both ZFNs and TALEN constructs have similar properties, the difference between these engineered nucleases is in their DNA
497:
endonuclease which need to dimerize to cleave the double-strand DNA. The two proteins recognize two DNA sequences that are a few nucleotides apart. Linking the two zinc finger proteins to their respective sequences brings the two FokI domains closer together. FokI requires dimerization to have
464:(ZFN), likely because of more stringent DNA sequence recognition; however, the construction of sequence-specific enzymes for all possible sequences is costly and time-consuming, as one is not benefiting from combinatorial possibilities that methods such as ZFNs and TALEN-based fusions utilize. 91:
Genome editing was pioneered in the 1990s, before the advent of the common current nuclease-based gene editing platforms but its use was limited by low efficiencies of editing. Genome editing with engineered nucleases, i.e. all three major classes of these enzymes—zinc finger nucleases (ZFNs),
639:
CRISPR nucleases have a slightly lower precision when compared to the TALE nucleases. This is caused by the need of having a specific nucleotide at one end in order to produce the guide RNA that CRISPR uses to repair the double-strand break it induces. It has been shown to be the quickest and
1169:
The CRISPR-Cas9 system can be programmed to modulate the population of any bacterial species by targeting clinical genotypes or epidemiological isolates. It can selectively enable the beneficial bacterial species over the harmful ones by eliminating pathogen, which gives it an advantage over
622:
ARCUT stands for artificial restriction DNA cutter, it is a technique developed by Komiyama. This method uses pseudo-complementary peptide nucleic acid (pcPNA), for identifying cleavage site within the chromosome. Once pcPNA specifies the site, excision is carried out by cerium (CE) and EDTA
799:
Thanks to the parallel development of single-cell transcriptomics, genome editing and new stem cell models we are now entering a scientifically exciting period where functional genetics is no longer restricted to animal models but can be performed directly in human samples. Single-cell gene
1333:
issued a report in February 2017 giving qualified support to human genome editing. They recommended that clinical trials for genome editing might one day be permitted once answers have been found to safety and efficiency problems "but only for serious conditions under stringent oversight."
730:
which aims to engineer cells and organisms to perform novel functions, is likely to benefit from the ability of engineered nuclease to add or remove genomic elements and therefore create complex systems. In addition, gene functions can be studied using stem cells with engineered nucleases.
452:
A large bank containing several tens of thousands of protein units has been created. These units can be combined to obtain chimeric meganucleases that recognize the target site, thereby providing research and development tools that meet a wide range of needs (fundamental research, health,
780:
embryo culture) allows for genome editing directly in fertilised oocytes using synthetic highly specific endonucleases. RNA-guided endonucleases:clustered regularly interspaced short palindromic repeats associated Cas9 (CRISPR/Cas9) are a new tool, further increasing the range of methods
383:
to the flanking sequences of a DSB. This will result in the desired change being inserted at the site of the DSB. While HDR based gene editing is similar to the homologous recombination based gene targeting, the rate of recombination is increased by at least three orders of magnitude.
648:
TALEN methods or RNA-guided nucleases, while TALEN and RNA-guided approaches tend to have the greatest efficiency and fewer off-target effects. Based on the maximum theoretical distance between DNA binding and nuclease activity, TALEN approaches result in the greatest precision.
850:
In addition, TALEN-based genome engineering has been extensively tested and optimized for use in plants. TALEN fusions have also been used by a U.S. food ingredient company, Calyxt, to improve the quality of soybean oil products and to increase the storage potential of potatoes
567:
TAL effectors consists of repeated domains, each of which contains a highly conserved sequence of 34 amino acids, and recognize a single DNA nucleotide within the target site. The nuclease can create double strand breaks at the target site that can be repaired by error-prone
54:
that randomly inserts genetic material into a host genome, genome editing targets the insertions to site-specific locations. The basic mechanism involved in genetic manipulations through programmable nucleases is the recognition of target genomic loci and binding of effector
795:
is a genetically modified Atlantic salmon developed by AquaBounty Technologies. The growth hormone-regulating gene in the Atlantic salmon is replaced with the growth hormone-regulating gene from the Pacific Chinook salmon and a promoter sequence from the ocean pout
449:
specific meganucelases in a method named rationally designed meganuclease. Another approach involves using computer models to try to predict as accurately as possible the activity of the modified meganucleases and the specificity of the recognized nucleic sequence.
1173:
Antiviral applications for therapies targeting human viruses such as HIV, herpes, and hepatitis B virus are under research. CRISPR can be used to target the virus or the host to disrupt genes encoding the virus cell-surface receptor proteins. In November 2018,
184:, would be held responsible for any related adverse consequences. A cautionary perspective on the possible blind spots and risks of CRISPR and related biotechnologies has been recently discussed, focusing on the stochastic nature of cellular control processes. 712:
As of 2012 efficient genome editing had been developed for a wide range of experimental systems ranging from plants to animals, often beyond clinical interest, and was becoming a standard experimental strategy in research labs. The recent generation of rat,
600:
to protect against viruses. They consist of short sequences that originate from viral genomes and have been incorporated into the bacterial genome. Cas (CRISPR associated proteins) process these sequences and cut matching viral DNA sequences. By introducing
3657:
Yaskowiak, Edward S.; Shears, Margaret A.; Agarwal-Mawal, Alka; Fletcher, Garth L. (2006). "Characterization and multi-generational stability of the growth hormone transgene (EO-1α) responsible for enhanced growth rates in Atlantic Salmon".
614:
strands, and thus avoids the random insertion and deletions associated with DNA strand breakage. It is only appropriate for precise editing requiring single nucleotide changes and has found to be highly efficient for this type of editing.
636:
independent from others, resulting in a higher number of target sites with high precision. New TALE nucleases take about one week and a few hundred dollars to create, with specific expertise in molecular biology and protein engineering.
375:(HDR). NHEJ uses a variety of enzymes to directly join the DNA ends while the more accurate HDR uses a homologous sequence as a template for regeneration of missing DNA sequences at the break point. This can be exploited by creating a 668:
Chemically combined, synthetic single-stranded DNA (ssDNA) and a pool of oligionucleotides are introduced at targeted areas of the cell thereby creating genetic modifications. The cyclical process involves transformation of ssDNA (by
1122:
Extensive research has been done in cells and animals using CRISPR-Cas9 to attempt to correct genetic mutations which cause genetic diseases such as Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes.
240:
within an organism genome. It has also enabled the editing of specific sequences within a genome as well as reduced off target effects. This could be used for research purposes, by targeting mutations to specific genes, and in
270:(HR). By creating DNA constructs that contain a template that matches the targeted genome sequence it is possible that the HR processes within the cell will insert the construct at the desired location. Using this method on 201:
In February 2020, a US trial safely showed CRISPR gene editing on 3 cancer patients. In 2020 Sicilian Rouge High GABA, a tomato that makes more of an amino acid said to promote relaxation, was approved for sale in Japan.
1234:
addition, zinc-fingers used in ZFNs are seldom completely specific, and some may cause a toxic reaction. However, the toxicity has been reported to be reduced by modifications done on the cleavage domain of the ZFN.
2022:
Altae-Tran, Han; Kannan, Soumya; Demircioglu, F. Esra; Oshiro, Rachel; Nety, Suchita P.; McKay, Luke J.; Dlakić, Mensur; Inskeep, William P.; Makarova, Kira S.; Macrae, Rhiannon K.; Koonin, Eugene V. (2021-10-01).
2503:
Arnould S, Chames P, Perez C, Lacroix E, Duclert A, Epinat JC, et al. (January 2006). "Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets".
1302:. According to a September 2016 report by the Nuffield Council on Bioethics in the future it may be possible to enhance people with genes from other organisms or wholly synthetic genes to for example improve 785:
In particular CRISPR/Cas9 engineered endonucleases allows the use of multiple guide RNAs for simultaneous Knockouts (KO) in one step by cytoplasmic direct injection (CDI) on mammalian zygotes.
1397:
was awarded to Mario Capecchi, Martin Evans and Oliver Smithies "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells."
2610:
Redondo P, Prieto J, Muñoz IG, Alibés A, Stricher F, Serrano L, et al. (November 2008). "Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases".
2861:"Zinc finger nucleases targeting the glucocorticoid receptor allow IL-13 zetakine transgenic CTLs to kill glioblastoma cells in vivo in the presence of immunosuppressing glucocorticoids" 1069: 3966:
Shukla VK, Doyon Y, Miller JC, DeKelver RC, Moehle EA, Worden SE, et al. (May 2009). "Precise genome modification in the crop species Zea mays using zinc-finger nucleases".
493:
The method generally adopted for this involves associating two DNA binding proteins – each containing 3 to 6 specifically chosen zinc fingers – with the catalytic domain of the
1249:
Genome editing occurs also as a natural process without artificial genetic engineering. The agents that are competent to edit genetic codes are viruses or subviral RNA-agents.
428:
family which are characterized by their capacity to recognize and cut large DNA sequences (from 14 to 40 base pairs). The most widespread and best known meganucleases are the
524:
are research and development tools that have already been used to modify a range of genomes, in particular by the laboratories in the Zinc Finger Consortium. The US company
4984: 575:
TALEN constructs are used in a similar way to designed zinc finger nucleases, and have three advantages in targeted mutagenesis: (1) DNA binding specificity is higher, (2)
453:
agriculture, industry, energy, etc.) These include the industrial-scale production of two meganucleases able to cleave the human XPC gene; mutations in this gene result in
683:
to produce five times the normal amount of lycopene, an antioxidant normally found in tomato seeds and linked to anti-cancer properties. They applied MAGE to optimize the
2707:
Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, et al. (December 2002). "Induction of angiogenesis in a mouse model using engineered transcription factors".
228:
as method of introducing new genetic elements into organisms has been around since the 1970s. One drawback of this technology has been the random nature with which the
5501: 1104:
often the case. The expression of the partially replaced genes is also more consistent with normal cell biology than full genes that are carried by viral vectors.
5090: 290:
patterns. In recognition of their discovery of how homologous recombination can be used to introduce genetic modifications in mice through embryonic stem cells,
498:
nuclease activity and this means the specificity increases dramatically as each nuclease partner would recognize a unique DNA sequence. To enhance this effect,
660:
Synthetic DNA is repeatedly introduced at multiple targeted areas of the chromosome and/or loci and then is replicated producing cells with/without mutations.
776:
The combination of recent discoveries in genetic engineering, particularly gene editing and the latest improvement in bovine reproduction technologies (e.g.
5009: 4324:"ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy" 1997: 1298:
notes that "the new technologies with genome editing will allow it to be used on individuals (...) to have (...) healthier children" –
1166:, the vector for malaria. This technique has further implications in eradicating other vector borne diseases such as yellow fever, dengue, and Zika. 2992:"An improved method for TAL effectors DNA-binding sites prediction reveals functional convergence in TAL repertoires of Xanthomonas oryzae strains" 4428: 1385:, that could affect humans. Furthermore, there are additional concerns about the ecological risks of releasing gene drives into wild populations. 5305:"The mousepox experience. An interview with Ronald Jackson and Ian Ramshaw on dual-use research. Interview by Michael J. Selgelid and Lorna Weir" 556: 406: 236:, which can impair or alter other genes within the organism. Although, several methods have been discovered which target the inserted genes to 116: 3457:
Gallagher RR, Li Z, Lewis AO, Isaacs FJ (October 2014). "Rapid editing and evolution of bacterial genomes using libraries of synthetic DNA".
3302:"Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application" 5058: 4961: 3050: 605:
containing Cas genes and specifically constructed CRISPRs into eukaryotic cells, the eukaryotic genome can be cut at any desired position.
5281: 2096: 1076: 5408: 245:. By inserting a functional gene into an organism and targeting it to replace the defective one it could be possible to cure certain 536:
for therapeutic purposes. Modified T lymphocytes are currently undergoing phase I clinical trials to treat a type of brain tumor (
457:, a severe monogenic disorder that predisposes the patients to skin cancer and burns whenever their skin is exposed to UV rays. 5427:"WHO launches global registry on human genome editing." PharmaBiz, 31 Aug. 2019. Gale General OneFile, Accessed 27 Apr. 2020. 2816:
Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (September 2010). "Genome editing with engineered zinc finger nucleases".
1190:, had been born a few weeks earlier. He said that the girls still carried functional copies of CCR5 along with disabled CCR5 ( 5256: 4906: 4681: 2138: 1394: 923: 303: 5482: 1973: 708:
Plants, animals and human genes that are successfully targeted using ZFN, which demonstrates the generality of this approach
644: 576: 315: 1111:
in an 11-month old child in 2015. Modified donor T cells were engineered to attack the leukemia cells, to be resistant to
882:
for plant application. To improve Cas9 delivery in live plants, viruses are being used more effective transgene delivery.
4728: 1822: 5353: 5097: 4648: 1924:
Cheong KH, Koh JM, Jones MC (July 2019). "Black Swans of CRISPR: Stochasticity and Complexity of Genetic Regulation".
4576: 4567:"Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II" 1735: 23:
The different generations of nucleases used for genome editing and the DNA repair pathways used to modify target DNA.
2894:"Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo" 314:
If a vital gene is knocked out it can prove lethal to the organism. In order to study the function of these genes
76: 4600:"A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae" 2123:"Chapter 8.5: Gene Replacement and Transgenic Animals: DNA Is Transferred into Eukaryotic Cells in Various Ways" 596:(Clustered Regularly Interspaced Short Palindromic Repeats) are genetic elements that bacteria use as a kind of 5231: 1655: 684: 51: 5205: 1718:
Tan WS, Carlson DF, Walton MW, Fahrenkrug SC, Hackett PB (2012). "Precision Editing of Large Animal Genomes".
4108: 3744:"The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy" 1441: 1358: 4460:
Couzin-Frankel J (November 2015). "CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy".
4279:
Paul JW, Qi Y (July 2016). "CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects".
1330: 1326: 1108: 1040: 904: 5173: 5032: 1373:
virus that would cause infertility as the provided sensitive information could lead to the manufacture of
1369:
that explored the potential control of mice, a major pest in Australia, by infecting them with an altered
1314:
has compiled a list of potential genetic modifications for possibly advantageous traits such as less need
1194:) and were still vulnerable to HIV. The work was widely condemned as unethical, dangerous, and premature. 1361:, the simplicity and low cost of tools to edit the genetic code will allow amateurs – or " 2413:
Seligman LM, Chisholm KM, Chevalier BS, Chadsey MS, Edwards ST, Savage JH, Veillet AL (September 2002).
2201: 3364:
Barrangou R, Doudna JA (September 2016). "Applications of CRISPR technologies in research and beyond".
1446: 1351: 1318:, cognition-related changes that protect against Alzheimer's disease, disease resistances and enhanced 1311: 1135: 1062: 569: 376: 368: 209:(not the rest of the UK) planned to remove restrictions on gene-edited plants and animals, moving from 92:
transcription activator-like effector nucleases (TALENs) and engineered meganucleases—were selected by
80: 4757:"Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety" 1281: 1116: 969: 445: 352: 173: 169: 146: 72: 5122: 4700: 2990:
Pérez-Quintero AL, Rodriguez-R LM, Dereeper A, López C, Koebnik R, Szurek B, Cunnac S (2013-07-15).
2025:"The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases" 3503:
McMahon MA, Rahdar M, Porteus M (December 2011). "Gene editing: not just for translation anymore".
1401: 745: 372: 267: 150: 64: 5379: 696:
biomedical engineering, synthetic biology, pharmaceutical, agricultural, and chemical industries.
5548: 4132:"Improved soybean oil quality by targeted mutagenesis of the fatty acid desaturase 2 gene family" 1261:
these problems improves donor organ function, which brings this application closer to a reality.
1202: 980: 913: 656: 188: 3058: 2563:"Computational reprogramming of homing endonuclease specificity at multiple adjacent base pairs" 4598:
Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C, Katsanos D, et al. (January 2016).
4322:
Monga, Isha; Qureshi, Abid; Thakur, Nishant; Gupta, Amit Kumar; Kumar, Manoj (September 2017).
3845:
Zhang F, Maeder ML, Unger-Wallace E, Hoshaw JP, Reyon D, Christian M, et al. (June 2010).
3604: 1405: 1362: 1050: 1045: 195: 3141:"To cleave or not to cleave: therapeutic gene editing with and without programmable nucleases" 2366:"A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences" 1381:
who might use the knowledge to create vaccine resistant strains of other pox viruses, such as
1315: 1295: 1019: 1004: 521: 515: 483: 323: 319: 19: 5404: 2541:
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
1264:
In plants, genome editing is seen as a viable solution to the conservation of biodiversity.
356: 4918: 4228: 3975: 3917: 3858: 3801: 3559: 3196: 3185:"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage" 3093: 3003: 2763: 2619: 2036: 1198: 1147: 1131: 1127: 951: 525: 461: 402: 364: 336: 138: 112: 5466: 4905:
Johnson JA, Altwegg R, Evans DM, Ewen JG, Gordon IJ, Pettorelli N, Young JK (2016-04-01).
4539: 8: 5521: 4171:
Clasen BM, Stoddard TJ, Luo S, Demorest ZL, Li J, Cedrone F, et al. (January 2016).
3847:"High frequency targeted mutagenesis in Arabidopsis thaliana using zinc finger nucleases" 1848: 1366: 1014: 871: 833: 792: 588: 433: 332: 271: 225: 181: 60: 39: 4922: 4232: 4130:
Haun W, Coffman A, Clasen BM, Demorest ZL, Lowy A, Ray E, et al. (September 2014).
3979: 3921: 3862: 3805: 3742:
Arnould S, Delenda C, Grizot S, Desseaux C, Pâques F, Silva GH, Smith J (January 2011).
3563: 3200: 3097: 3007: 2767: 2623: 2040: 5454: 5329: 5304: 4942: 4882: 4857: 4830: 4805: 4781: 4756: 4624: 4599: 4571: 4520: 4404: 4379: 4350: 4323: 4304: 4251: 4216: 4173:"Improving cold storage and processing traits in potato through targeted gene knockout" 4051: 4018: 3999: 3940: 3905: 3881: 3846: 3822: 3789: 3683: 3632: 3580: 3547: 3528: 3482: 3432: 3407:
Kim H, Kim JS (May 2014). "A guide to genome engineering with programmable nucleases".
3389: 3334: 3301: 3282: 3217: 3184: 3026: 2991: 2967: 2942: 2918: 2893: 2841: 2732: 2689: 2643: 2587: 2562: 2390: 2365: 2341: 2289: 2078: 2065: 2024: 1949: 1899: 1746: 1727: 1695: 1670: 1596: 1544: 1489: 974: 756: 56: 4100: 3906:"Site-directed mutagenesis in Arabidopsis using custom-designed zinc finger nucleases" 2877: 2860: 2561:
Ashworth J, Taylor GK, Havranek JJ, Quadri SA, Stoddard BL, Baker D (September 2010).
2480: 2463: 2462:
Chevalier BS, Kortemme T, Chadsey MS, Baker D, Monnat RJ, Stoddard BL (October 2002).
2439: 2414: 870:
is introduced directly into the plant genome by a T4SS mechanism. Cas9 and gRNA-based
460:
Meganucleases have the benefit of causing less toxicity in cells than methods such as
262:
Early methods to target genes to certain sites within a genome of an organism (called
5458: 5334: 5181: 4934: 4887: 4835: 4786: 4656: 4629: 4512: 4477: 4436: 4409: 4355: 4296: 4256: 4194: 4153: 4056: 3991: 3945: 3886: 3827: 3788:
Townsend JA, Wright DA, Winfrey RJ, Fu F, Maeder ML, Joung JK, Voytas DF (May 2009).
3765: 3724: 3675: 3636: 3624: 3585: 3520: 3474: 3424: 3381: 3339: 3321: 3286: 3274: 3266: 3222: 3162: 3121: 3116: 3081: 3031: 2972: 2923: 2845: 2833: 2791: 2786: 2751: 2724: 2681: 2635: 2592: 2521: 2485: 2444: 2395: 2333: 2281: 2246: 2241: 2224: 2180: 2134: 2127: 2082: 2070: 2052: 1953: 1941: 1903: 1891: 1875: 1792: 1751: 1731: 1700: 1636: 1588: 1536: 1528: 1493: 1431: 1374: 1291: 1009: 897: 727: 597: 380: 131: 100: 4946: 4524: 4508: 3687: 3486: 3393: 2736: 2693: 2345: 2293: 1548: 1322:
abilities along with some of the associated studies and potential negative effects.
840:
editing to inactivate the endogenous banana streak virus in the B genome of banana (
409:), meganucleases and the clustered regularly interspaced short palindromic repeats ( 5446: 5324: 5316: 4926: 4877: 4869: 4825: 4817: 4776: 4768: 4619: 4611: 4504: 4469: 4399: 4391: 4345: 4335: 4308: 4288: 4246: 4236: 4184: 4143: 4087: 4046: 4038: 4003: 3983: 3935: 3925: 3876: 3866: 3817: 3809: 3790:"High-frequency modification of plant genes using engineered zinc-finger nucleases" 3755: 3714: 3667: 3616: 3575: 3567: 3532: 3512: 3466: 3436: 3416: 3373: 3329: 3313: 3256: 3212: 3204: 3152: 3111: 3101: 3021: 3011: 2962: 2954: 2913: 2905: 2872: 2825: 2781: 2771: 2716: 2673: 2647: 2627: 2582: 2574: 2539: 2513: 2475: 2434: 2426: 2385: 2377: 2323: 2273: 2236: 2170: 2159:"From Gene Targeting to Genome Editing: Transgenic animals applications and beyond" 2060: 2044: 1933: 1883: 1782: 1741: 1723: 1690: 1682: 1626: 1600: 1580: 1520: 1481: 1347: 1269: 1178:
announced that he had edited two human embryos, to attempt to disable the gene for
1107:
The first clinical use of TALEN-based genome editing was in the treatment of CD19+
679: 479: 246: 237: 191: 94: 4566: 2958: 2364:
Smith J, Grizot S, Arnould S, Duclert A, Epinat JC, Chames P, et al. (2006).
2175: 2158: 808: 4473: 4092: 4075: 3242: 3016: 2122: 1409: 1299: 1143: 960: 670: 528:
uses zinc finger nucleases to carry out research into the genetic engineering of
327: 299: 287: 275: 5437:
Saurabh S (March 2021). "Genome Editing: Revolutionizing the Crop Improvement".
5147: 4772: 2892:
Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, et al. (August 2010).
1472:
Saurabh S (March 2021). "Genome Editing: Revolutionizing the Crop Improvement".
396:
Groups of engineered nucleases. Matching colors signify DNA recognition patterns
141:(DSBs) at desired locations in the genome. The induced double-strand breaks are 5450: 4873: 4806:"Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders" 4221:
Proceedings of the National Academy of Sciences of the United States of America
3910:
Proceedings of the National Academy of Sciences of the United States of America
3851:
Proceedings of the National Academy of Sciences of the United States of America
3620: 3571: 3317: 3086:
Proceedings of the National Academy of Sciences of the United States of America
2756:
Proceedings of the National Academy of Sciences of the United States of America
1887: 1485: 1307: 291: 263: 210: 4985:"How DIY bio-hackers are changing the conversation around genetic engineering" 4292: 4042: 3719: 3702: 3671: 3261: 3245:"APOBECs orchestrate genomic and epigenomic editing across health and disease" 3244: 2517: 2464:"Design, activity, and structure of a highly specific artificial endonuclease" 2277: 2157:
Rocha-Martins M, Cavalheiro GR, Matos-Rodrigues GE, Martins RA (August 2015).
1568: 1524: 5542: 5502:"Scientific split - the human genome breakthrough dividing former colleagues" 5185: 4938: 4660: 4440: 3760: 3743: 3325: 3270: 2156: 2056: 1998:"US Trial Shows 3 Cancer Patients Had Their Genomes Altered Safely by CRISPR" 1876:"China set to introduce gene-editing regulation following CRISPR-baby furore" 1532: 1436: 1287: 1222: 1206: 1197:
In January 2019, scientists in China reported the creation of five identical
1187: 421: 283: 279: 4241: 3930: 3871: 3106: 2121:
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000).
2048: 704: 119:(TALEN), and the clustered regularly interspaced short palindromic repeats ( 5338: 5320: 4891: 4839: 4790: 4682:"Amid uproar, Chinese scientist defends creating gene-edited babies - STAT" 4633: 4516: 4481: 4413: 4359: 4300: 4260: 4198: 4157: 4060: 4017:
Tripathi JN, Ntui VO, Ron M, Muiruri SK, Britt A, Tripathi L (2019-01-31).
3995: 3949: 3890: 3831: 3769: 3728: 3679: 3628: 3589: 3524: 3478: 3470: 3428: 3385: 3343: 3278: 3226: 3166: 3035: 2976: 2927: 2837: 2776: 2728: 2685: 2639: 2596: 2525: 2489: 2448: 2399: 2337: 2285: 2264:
Stoddard BL (February 2005). "Homing endonuclease structure and function".
2184: 2074: 1945: 1937: 1895: 1796: 1755: 1704: 1640: 1540: 1508: 1378: 1303: 1238: 1100: 946: 867: 841: 817: 560: 537: 533: 425: 401:
discovered and bioengineered to date. These are the Zinc finger nucleases (
295: 242: 177: 108: 4340: 3125: 2795: 2752:"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain" 2250: 1787: 1770: 1592: 1507:
Bak, Rasmus O.; Gomez-Ospina, Natalia; Porteus, Matthew H. (August 2018).
1225:. The monkey clones were made in order to study several medical diseases. 4705: 2578: 2430: 2381: 1426: 1421: 1201:
gene-edited monkeys, using the same cloning technique that was used with
1112: 1024: 995: 856: 837: 476: 441: 214: 4962:"Geneticists Are Concerned Transhumanists Will Use CRISPR on Themselves" 4395: 3987: 3813: 3243:
Cervantes-Gracia K, Gramalla-Schmitz A, Weischedel J, Chahwan R (2021).
3208: 3157: 3140: 2631: 2097:"New programmable gene editing proteins found outside of CRISPR systems" 1686: 1584: 4821: 4495:
Mentis AF (December 2016). "Epigenomic engineering for Down syndrome".
3548:"Embryonic POU5F1 is Required for Expanded Bovine Blastocyst Formation" 3516: 2720: 2677: 2328: 2311: 1631: 1614: 1265: 1218: 1175: 1159: 875: 761: 751: 529: 392: 165: 142: 4930: 4380:"Progress and prospects: zinc-finger nucleases as gene therapy agents" 4189: 4172: 4148: 4131: 2989: 2415:"Mutations altering the cleavage specificity of a homing endonuclease" 367:(DSB) repair mechanics. There are two major pathways that repair DSB; 98:
as the 2011 Method of the Year. The CRISPR-Cas system was selected by
4615: 3377: 2909: 1253:
will also be at work correcting the DSB with lower mutational rates.
1191: 986: 714: 548: 4907:"Is there a future for genome-editing technologies in conservation?" 4858:"Development and applications of CRISPR-Cas9 for genome engineering" 3656: 3420: 2829: 608: 4076:"Recent developments in genome editing for potential use in plants" 1823:"Rewriting the book of life: a new era in precision genome editing" 1382: 1370: 1319: 918: 626: 429: 154: 134: 579:
are lower, and (3) construction of DNA-binding domains is easier.
198:, which costs US and European pig farmers $ 2.6 billion annually. 164:
reported, in light of the purported creation by Chinese scientist
4733: 4544: 2943:"ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering" 2225:"Genetic manipulation of genomes with rare-cutting endonucleases" 2021: 722: 651: 602: 206: 5282:"Top U.S. Intelligence Official Calls Gene Editing a WMD Threat" 5123:"George Church told us why he's listing "superhuman" gene hacks" 2412: 789:
a more sustainable environment and better welfare for the fish.
734:
Listed below are some specific tasks this method can carry out:
137:, or "molecular scissors". These nucleases create site-specific 5506: 5096:. Nuffield Council on Bioethics. September 2016. Archived from 4755:
Teboul L, Herault Y, Wells S, Qasim W, Pavlovic G (June 2020).
1210: 941: 593: 410: 233: 120: 47: 5232:"Worldwide Threat Assessment of the US Intelligence Community" 4540:"Tests suggest scientists achieved 1st 'in body' gene editing" 3844: 3701:
Ortega NM, Winblad N, Plaza Reyes A, Lanner F (October 2018).
3700: 2461: 1451: 718: 502:
have been engineered that can only function as heterodimers.
432:
in the LAGLIDADG family, which owe their name to a conserved
161: 5059:"Experts warn home 'gene editing' kits pose risk to society" 4729:"China's Latest Cloned-Monkey Experiment Is an Ethical Mess" 4429:"A Cell Therapy Untested in Humans Saves a Baby With Cancer" 3741: 2560: 2120: 1974:"U.K. set to loosen rules for gene-edited crops and animals" 1671:"Genome-scale engineering for systems and synthetic biology" 1344:
Worldwide Threat Assessment of the US Intelligence Community
379:
with the desired genetic elements within a sequence that is
176:), the drafting of regulations that anyone manipulating the 107:
As of 2015 four families of engineered nucleases were used:
1346:
statement United States Director of National Intelligence,
1214: 1179: 507: 499: 494: 124: 68: 3183:
Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (May 2016).
1717: 1146:. Clinical trials by Sangamo involving gene editing using 677:
in 2009, where Church and colleagues were able to program
623:(chemical mixture), which performs the splicing function. 4170: 4129: 3965: 3545: 3139:
Woolf TM, Gurumurthy CB, Boyce F, Kmiec EB (April 2017).
3138: 3082:"Toward the therapeutic editing of mutated RNA sequences" 2502: 2363: 1183: 1139: 363:
A common form of Genome editing relies on the concept of
229: 127:) system. Nine genome editors were available as of 2017. 43: 4597: 2609: 771: 4904: 4754: 4649:"Mutant mosquitoes: Can gene editing kill off malaria?" 4321: 3787: 3605:"Application of genome editing in aquatic farm animals" 3546:
Daigneault BW, Rajput S, Smith GW, Ross PJ (May 2018).
1268:
are a potential tool to alter the reproductive rate of
803: 4016: 3456: 2554: 1569:"Therapeutic repair of mutated nucleic acid sequences" 1506: 1412:
for "the development of a method for genome editing".
1221:
in creating the first ever gene-modified human babies
862:
A common delivery method for CRISPR/Cas9 in plants is
5174:"Human Gene Editing Receives Science Panel's Support" 3293: 2815: 117:
transcription activator-like effector-based nucleases
5275: 5273: 4027:
spp. overcomes a major challenge in banana breeding"
3502: 3079: 2749: 2706: 847:) to overcome a major challenge in banana breeding. 563:, DNA-binding proteins excreted by plant pathogenic 405:), transcription-activator like effector nucleases ( 5257:"Genome editing: Is it a national security threat?" 4698: 3182: 2891: 1272:, although there are significant associated risks. 1246:productions due to their precision and efficiency. 812:
Overview of GEEN workflow and editing possibilities
424:, discovered in the late 1980s, are enzymes in the 318:(SSR) were used. The two most common types are the 3903: 2664:Baker M (January 2012). "Gene-editing nucleases". 2312:"Primer: genome editing with engineered nucleases" 2126: 1775:The International Journal of Developmental Biology 1653: 1126:In February 2019, medical scientists working with 130:In 2018, the common methods for such editing used 46:is inserted, deleted, modified or replaced in the 5483:"Customized Human Genes: New Promises and Perils" 5270: 3452: 3450: 3448: 3446: 3359: 3357: 3355: 3353: 3080:Woolf TM, Chase JM, Stinchcomb DT (August 1995). 2940: 2750:Kim YG, Cha J, Chandrasegaran S (February 1996). 2305: 2303: 1294:. Australian biologist and Professor of Genetics 609:Editing by nucleobase modification (Base editing) 194:engineered pigs resistant to a virus that causes 5540: 3703:"Functional genetics of early human development" 2202:"The Nobel Prize in Physiology or Medicine 2007" 1656:"Breakthrough of the Year: CRISPR makes the cut" 627:Precision and efficiency of engineered nucleases 5052: 5050: 3783: 3781: 3779: 3498: 3496: 3363: 2152: 2150: 1816: 1814: 1812: 1810: 1808: 1806: 1242:flanking DNA using high-throughput sequencing. 557:Transcription activator-like effector nucleases 331:organism that express the SSR under control of 5302: 5206:"Scientists OK genetically engineering babies" 4855: 4459: 4217:"Breaking news: plants mutate right on target" 3443: 3350: 2300: 1923: 1186:uses to enter cells. He said that twin girls, 726:therapy in humans. For instance, the field of 652:Multiplex Automated Genomic Engineering (MAGE) 4701:"Gene-edited disease monkeys cloned in China" 4315: 3707:Current Opinion in Genetics & Development 2811: 2809: 2807: 2805: 1849:"The future of genetic codes and BRAIN codes" 1162:to modify genes associated with sterility in 1070: 859:, and a reliable detection of mutated cases. 359:and genome editing using CRISPR-Cas nucleases 347: 196:porcine reproductive and respiratory syndrome 5085: 5083: 5081: 5079: 5047: 4720: 4692: 4591: 3897: 3838: 3776: 3493: 3236: 2700: 2455: 2147: 1867: 1803: 1768: 1357:According to a September 2016 report by the 1228: 4851: 4849: 4531: 3748:Protein Engineering, Design & Selection 2941:Gaj T, Gersbach CA, Barbas CF (July 2013). 2743: 2216: 2133:(4th ed.). W. H. Freeman and Company. 1820: 1762: 1607: 1290:see genome editing as a potential tool for 257: 4726: 4373: 4371: 4369: 4214: 3904:Osakabe K, Osakabe Y, Toki S (June 2010). 2802: 1771:"Gene targeting in plants: 25 years later" 1668: 1077: 1063: 855:induction of enzyme activity, the lack of 5467:"Special Issue on Human Germline Editing" 5354:"Australians Create a Deadly Mouse Virus" 5328: 5254: 5076: 4881: 4829: 4803: 4780: 4623: 4559: 4537: 4403: 4349: 4339: 4250: 4240: 4210: 4208: 4188: 4147: 4091: 4050: 3961: 3959: 3939: 3929: 3880: 3870: 3821: 3759: 3718: 3602: 3579: 3333: 3260: 3216: 3156: 3115: 3105: 3025: 3015: 2966: 2917: 2876: 2785: 2775: 2586: 2479: 2438: 2389: 2327: 2240: 2196: 2194: 2174: 2064: 1873: 1786: 1745: 1694: 1630: 4959: 4856:Hsu PD, Lander ES, Zhang F (June 2014). 4846: 4646: 4106: 2659: 2657: 2359: 2357: 2355: 2309: 2263: 2163:Anais da Academia Brasileira de Ciências 1971: 807: 703: 655: 547: 467: 391: 351: 309: 18: 5436: 5377: 5229: 4699:Science China Press (23 January 2019). 4426: 4377: 4366: 4073: 1654:Science News Staff (17 December 2015). 1471: 1454:, a ssDNA-guided Argonaute endonuclease 1153: 387: 5541: 5499: 5380:"Lab creates killer virus by accident" 5171: 5056: 4804:Im W, Moon J, Kim M (September 2016). 4679: 4497:Neuroscience and Biobehavioral Reviews 4494: 4278: 4205: 3956: 3406: 2191: 1846: 1395:Nobel Prize for Physiology or Medicine 1350:, named genome editing as a potential 1205:– the first ever cloned monkeys - and 304:Nobel Prize for Physiology or Medicine 5351: 5303:Jackson R, Ramshaw I (January 2010). 4982: 4274: 4272: 4270: 3178: 3176: 3048: 2663: 2654: 2352: 2222: 1967: 1965: 1963: 1566: 1134:, announced the first ever "in body" 924:Registry of Standard Biological Parts 772:Targeted gene modification in animals 552:General overview of the TALEN process 5279: 5030: 3299: 2858: 1562: 1560: 1558: 1275: 804:Targeted gene modification in plants 5411:from the original on 7 October 2020 5405:"The Nobel Prize in Chemistry 2020" 5091:"Genome editing: an ethical review" 4019:"CRISPR/Cas9 editing of endogenous 3300:Khan, Sikandar Hayat (2019-06-07). 3042: 1117:detection by the host immune system 50:of a living organism. Unlike early 13: 5430: 4640: 4267: 4109:"These Are Not Your Father's GMOs" 3173: 1960: 1728:10.1016/B978-0-12-404742-6.00002-8 1182:, which codes for a receptor that 1158:Researchers have used CRISPR-Cas9 104:as 2015 Breakthrough of the Year. 75:), and the repair of DSBs through 14: 5560: 5012:. Pew Research Center. 2016-07-26 4727:Mandelbaum RF (23 January 2019). 4577:U.S. National Library of Medicine 1555: 540:) and in the fight against AIDS. 252: 180:by gene-editing techniques, like 3306:Molecular Therapy. Nucleic Acids 1722:. Vol. 80. pp. 37–97. 416: 5439:Plant Molecular Biology Reporte 5397: 5371: 5345: 5296: 5248: 5223: 5198: 5165: 5140: 5115: 5024: 5002: 4976: 4953: 4898: 4797: 4748: 4673: 4538:Marchione M (7 February 2019). 4509:10.1016/j.neubiorev.2016.09.012 4488: 4453: 4420: 4164: 4123: 4107:Regalado A (19 December 2017). 4067: 4010: 3735: 3694: 3650: 3596: 3539: 3400: 3132: 3073: 2983: 2934: 2885: 2852: 2603: 2532: 2496: 2406: 2266:Quarterly Reviews of Biophysics 2257: 2114: 2089: 2015: 1990: 1917: 1840: 1474:Plant Molecular Biology Reporte 1094: 890:Part of a series of articles on 699: 282:. It has also been possible to 77:homology-directed recombination 5230:Clapper JR (9 February 2016). 5057:Sample I (30 September 2016). 5033:"Engineering the Perfect Baby" 4215:Puchta H, Hohn B (June 2010). 3145:Nature Reviews. Drug Discovery 1711: 1662: 1647: 1509:"Gene Editing on Center Stage" 1500: 1465: 1388: 52:genetic engineering techniques 1: 5378:Radford T (10 January 2001). 4810:Journal of Movement Disorders 4680:Begley S (28 November 2018). 2959:10.1016/j.tibtech.2013.04.004 2878:10.1016/S1525-0016(16)39437-0 2481:10.1016/S1097-2765(02)00690-1 2176:10.1590/0001-3765201520140710 1972:Stokstad, Erik (2021-05-26). 1458: 1442:Transposons as a genetic tool 1359:Nuffield Council on Bioethics 905:Synthetic biological circuits 220: 217:, and guided by small ωRNAs. 5352:Broad WJ (23 January 2001). 4474:10.1126/science.350.6262.731 3049:Young S (11 February 2014). 3017:10.1371/journal.pone.0068464 2859:Reik A, et al. (2008). 2506:Journal of Molecular Biology 2242:10.1016/0168-9525(96)10019-6 1847:Church G (9 February 2017). 1331:National Academy of Medicine 1327:National Academy of Sciences 1217:technique allegedly used by 1209:, and the same gene-editing 1170:broad-spectrum antibiotics. 1109:acute lymphoblastic leukemia 153:(HR), resulting in targeted 63:(DSBs) in target DNA by the 7: 4773:10.1016/j.ymthe.2020.03.015 4378:Carroll D (November 2008). 4177:Plant Biotechnology Journal 4136:Plant Biotechnology Journal 2310:de Souza N (January 2012). 1769:Puchta H, Fauser F (2013). 1669:Esvelt KM, Wang HH (2013). 1415: 1089: 878:, which are transformed in 767:Targeted transgene addition 691:(DXP) metabolic pathway in 357:dsDNA-break repair pathways 232:is inserted into the hosts 16:Type of genetic engineering 10: 5565: 5500:Connor S (25 April 2014). 5451:10.1007/s11105-021-01286-7 5255:Warmflash D (2016-09-06). 4874:10.1016/j.cell.2014.05.010 4093:10.1093/biohorizons/hzx016 3621:10.1007/s11248-019-00163-0 3572:10.1038/s41598-018-25964-x 3318:10.1016/j.omtn.2019.02.027 1888:10.1038/d41586-019-01580-1 1486:10.1007/s11105-021-01286-7 1447:Germinal choice technology 1352:weapon of mass destruction 1279: 1136:human gene editing therapy 586: 570:non-homologous end-joining 369:non-homologous end joining 348:Double strand break repair 342: 316:site specific recombinases 274:led to the development of 86: 81:non-homologous end joining 5522:"What is genome editing?" 4960:Pearlman A (2015-12-03). 4647:Fletcher M (2018-08-11). 4293:10.1007/s00299-016-1985-z 4043:10.1038/s42003-019-0288-7 3720:10.1016/j.gde.2018.04.005 3672:10.1007/s11248-006-0020-5 3262:10.1016/j.tig.2021.07.003 2871:(Supplement 1): S13–S14. 2518:10.1016/j.jmb.2005.10.065 2278:10.1017/s0033583505004063 1828:. Boston Consulting Group 1675:Molecular Systems Biology 1615:"Method of the Year 2011" 1525:10.1016/j.tig.2018.05.004 1282:Human genetic enhancement 1237:In addition, research by 1229:Prospects and limitations 970:Artificial gene synthesis 750:Study gene function with 582: 446:high throughput screening 440:overcome this challenge, 365:DNA double stranded break 333:tissue specific promoters 174:Lulu and Nana controversy 147:nonhomologous end-joining 65:restriction endonucleases 4427:Pollack A (2015-11-05). 4074:Townson J (2017-01-01). 3603:Wargelius, Anna (2019). 3409:Nature Reviews. Genetics 3312:. Elsevier BV: 326–334. 2818:Nature Reviews. Genetics 1874:Cyranoski D (May 2019). 1402:Nobel Prize in Chemistry 1337: 834:gene expression cassette 746:chromosome rearrangement 617: 543: 532:and the modification of 373:homology directed repair 268:homologous recombination 258:Homologous recombination 170:first gene-edited humans 160:In May 2019, lawyers in 151:homologous recombination 5284:. MIT Technology Review 5172:Harmon A (2017-02-14). 5035:. MIT Technology Review 4242:10.1073/pnas.1006364107 4111:. MIT Technology Review 3931:10.1073/pnas.1000234107 3872:10.1073/pnas.0914991107 3107:10.1073/pnas.92.18.8298 2947:Trends in Biotechnology 2049:10.1126/science.abj6856 1821:Boglioli E, Richard M. 1567:Woolf TM (April 1998). 1203:Zhong Zhong and Hua Hua 981:Mycoplasma laboratorium 914:Synthetic gene database 866:-based transformation. 189:University of Edinburgh 5321:10.1038/embor.2009.270 4031:Communications Biology 3761:10.1093/protein/gzq083 3471:10.1038/nprot.2014.082 2777:10.1073/pnas.93.3.1156 2567:Nucleic Acids Research 2419:Nucleic Acids Research 2370:Nucleic Acids Research 2204:. The Nobel Foundation 2129:Molecular Cell Biology 1938:10.1002/bies.201900032 1625:(1): 1. January 2012. 1406:Emmanuelle Charpentier 1051:Do-it-yourself biology 1046:Open synthetic biology 857:off-target mutagenesis 813: 738:Targeted gene mutation 709: 661: 553: 397: 360: 302:were awarded the 2007 24: 5212:. Reuters. 2017-02-14 4341:10.1534/g3.117.044024 3055:MIT Technology Review 2223:Jasin M (June 1996). 1788:10.1387/ijdb.130194hp 1296:David Andrew Sinclair 1138:to permanently alter 1020:Expanded genetic code 1005:Nucleic acid analogue 816:Genome editing using 811: 707: 689:-xylulose 5-phosphate 659: 551: 522:Zinc finger nucleases 516:transcription factors 484:transcription factors 468:Zinc finger nucleases 455:Xeroderma pigmentosum 395: 355: 337:stages of development 310:Conditional targeting 113:zinc finger nucleases 22: 5407:. Nobel Foundation. 5152:arep.med.harvard.edu 5148:"Protective alleles" 4604:Nature Biotechnology 3615:(Suppl 2): 101–105. 3366:Nature Biotechnology 2898:Nature Biotechnology 2169:(2 Suppl): 1323–48. 1720:Advances in Genetics 1573:Nature Biotechnology 1154:Eradicating diseases 1148:Zinc Finger Nuclease 1142:- in a patient with 1132:Richmond, California 1128:Sangamo Therapeutics 1119:after introduction. 952:Synthetic immunology 872:expression cassettes 830:Arabidopsis thaliana 822:Arabidopsis thaliana 462:Zinc finger nuclease 388:Engineered nucleases 278:with targeted genes 272:embryonic stem cells 139:double-strand breaks 61:double-strand breaks 5487:Scientific American 5103:on 14 November 2016 5010:"Human Enhancement" 4989:The Washington Post 4923:2016AnCon..19...97J 4911:Animal Conservation 4396:10.1038/gt.2008.145 4233:2010PNAS..10711657P 4080:Bioscience Horizons 4023:in the B genome of 4021:banana streak virus 3988:10.1038/nature07992 3980:2009Natur.459..437S 3922:2010PNAS..10712034O 3863:2010PNAS..10712028Z 3814:10.1038/nature07845 3806:2009Natur.459..442T 3660:Transgenic Research 3609:Transgenic Research 3564:2018NatSR...8.7753D 3209:10.1038/nature17946 3201:2016Natur.533..420K 3158:10.1038/nrd.2017.42 3098:1995PNAS...92.8298W 3061:on 15 February 2014 3008:2013PLoSO...868464P 2768:1996PNAS...93.1156K 2632:10.1038/nature07343 2624:2008Natur.456..107R 2041:2021Sci...374...57A 1687:10.1038/msb.2012.66 1585:10.1038/nbt0498-341 1367:Journal of Virology 1150:(ZFN) are ongoing. 1130:, headquartered in 1015:Unnatural base pair 793:AquAdvantage salmon 645:off-target activity 589:CRISPR gene editing 526:Sangamo BioSciences 434:amino acid sequence 226:Genetic engineering 40:genetic engineering 5358:The New York Times 5178:The New York Times 4964:. Vice Motherboard 4822:10.14802/jmd.16029 4572:ClinicalTrials.gov 4433:The New York Times 4281:Plant Cell Reports 3552:Scientific Reports 3517:10.1038/nmeth.1811 2721:10.1038/nm1202-795 2678:10.1038/nmeth.1807 2579:10.1093/nar/gkq283 2431:10.1093/nar/gkf495 2382:10.1093/nar/gkl720 2329:10.1038/nmeth.1848 2229:Trends in Genetics 1632:10.1038/nmeth.1852 1513:Trends in Genetics 1375:biological weapons 975:Synthetic genomics 814: 757:Transgenic animals 710: 662: 577:off-target effects 554: 510:nuclease domains. 398: 361: 57:DNA-binding domain 32:genome engineering 25: 4931:10.1111/acv.12273 4761:Molecular Therapy 4579:. 2 February 2019 4190:10.1111/pbi.12370 4149:10.1111/pbi.12201 3255:(11): 1028–1043. 2140:978-0-7167-3136-8 2004:. 7 February 2020 1432:Epigenome editing 1292:human enhancement 1276:Human enhancement 1087: 1086: 1010:Xeno nucleic acid 898:Synthetic biology 892: 728:synthetic biology 688: 598:acquired immunity 482:occur in several 5556: 5535: 5533: 5532: 5517: 5515: 5514: 5496: 5494: 5493: 5478: 5462: 5421: 5420: 5418: 5416: 5401: 5395: 5394: 5392: 5390: 5375: 5369: 5368: 5366: 5364: 5349: 5343: 5342: 5332: 5300: 5294: 5293: 5291: 5289: 5277: 5268: 5267: 5265: 5263: 5252: 5246: 5245: 5243: 5241: 5236: 5227: 5221: 5220: 5218: 5217: 5202: 5196: 5195: 5193: 5192: 5169: 5163: 5162: 5160: 5158: 5144: 5138: 5137: 5135: 5133: 5119: 5113: 5112: 5110: 5108: 5102: 5095: 5087: 5074: 5073: 5071: 5069: 5054: 5045: 5044: 5042: 5040: 5028: 5022: 5021: 5019: 5017: 5006: 5000: 4999: 4997: 4995: 4980: 4974: 4973: 4971: 4969: 4957: 4951: 4950: 4902: 4896: 4895: 4885: 4868:(6): 1262–1278. 4853: 4844: 4843: 4833: 4801: 4795: 4794: 4784: 4767:(6): 1422–1431. 4752: 4746: 4745: 4743: 4741: 4724: 4718: 4717: 4715: 4713: 4696: 4690: 4689: 4677: 4671: 4670: 4668: 4667: 4644: 4638: 4637: 4627: 4616:10.1038/nbt.3439 4595: 4589: 4588: 4586: 4584: 4563: 4557: 4556: 4554: 4552: 4535: 4529: 4528: 4492: 4486: 4485: 4457: 4451: 4450: 4448: 4447: 4424: 4418: 4417: 4407: 4375: 4364: 4363: 4353: 4343: 4334:(9): 2931–2943. 4319: 4313: 4312: 4276: 4265: 4264: 4254: 4244: 4212: 4203: 4202: 4192: 4168: 4162: 4161: 4151: 4127: 4121: 4120: 4118: 4116: 4104: 4098: 4097: 4095: 4071: 4065: 4064: 4054: 4014: 4008: 4007: 3974:(7245): 437–41. 3963: 3954: 3953: 3943: 3933: 3901: 3895: 3894: 3884: 3874: 3857:(26): 12028–33. 3842: 3836: 3835: 3825: 3785: 3774: 3773: 3763: 3739: 3733: 3732: 3722: 3698: 3692: 3691: 3654: 3648: 3647: 3645: 3643: 3600: 3594: 3593: 3583: 3543: 3537: 3536: 3500: 3491: 3490: 3459:Nature Protocols 3454: 3441: 3440: 3404: 3398: 3397: 3378:10.1038/nbt.3659 3361: 3348: 3347: 3337: 3297: 3291: 3290: 3264: 3240: 3234: 3230: 3220: 3180: 3171: 3170: 3160: 3136: 3130: 3129: 3119: 3109: 3092:(18): 8298–302. 3077: 3071: 3070: 3068: 3066: 3057:. Archived from 3051:"Genome Surgery" 3046: 3040: 3039: 3029: 3019: 2987: 2981: 2980: 2970: 2938: 2932: 2931: 2921: 2910:10.1038/nbt.1663 2889: 2883: 2882: 2880: 2856: 2850: 2849: 2813: 2800: 2799: 2789: 2779: 2747: 2741: 2740: 2704: 2698: 2697: 2661: 2652: 2651: 2618:(7218): 107–11. 2607: 2601: 2600: 2590: 2558: 2552: 2551: 2550: 2549: 2536: 2530: 2529: 2500: 2494: 2493: 2483: 2459: 2453: 2452: 2442: 2410: 2404: 2403: 2393: 2361: 2350: 2349: 2331: 2307: 2298: 2297: 2261: 2255: 2254: 2244: 2220: 2214: 2213: 2211: 2209: 2198: 2189: 2188: 2178: 2154: 2145: 2144: 2132: 2118: 2112: 2111: 2109: 2108: 2093: 2087: 2086: 2068: 2019: 2013: 2012: 2010: 2009: 1994: 1988: 1987: 1985: 1984: 1969: 1958: 1957: 1921: 1915: 1914: 1912: 1910: 1871: 1865: 1864: 1862: 1860: 1844: 1838: 1837: 1835: 1833: 1827: 1818: 1801: 1800: 1790: 1766: 1760: 1759: 1749: 1715: 1709: 1708: 1698: 1666: 1660: 1659: 1651: 1645: 1644: 1634: 1611: 1605: 1604: 1564: 1553: 1552: 1504: 1498: 1497: 1469: 1348:James R. Clapper 1270:invasive species 1079: 1072: 1065: 961:Artificial cells 888: 885: 884: 874:are turned into 693:Escherichia coli 686: 680:Escherichia coli 565:Xanthomanos app. 247:genetic diseases 192:Roslin Institute 5564: 5563: 5559: 5558: 5557: 5555: 5554: 5553: 5539: 5538: 5530: 5528: 5520: 5512: 5510: 5507:The Independent 5491: 5489: 5481: 5465: 5433: 5431:Further reading 5425: 5424: 5414: 5412: 5403: 5402: 5398: 5388: 5386: 5376: 5372: 5362: 5360: 5350: 5346: 5301: 5297: 5287: 5285: 5278: 5271: 5261: 5259: 5253: 5249: 5239: 5237: 5234: 5228: 5224: 5215: 5213: 5204: 5203: 5199: 5190: 5188: 5170: 5166: 5156: 5154: 5146: 5145: 5141: 5131: 5129: 5121: 5120: 5116: 5106: 5104: 5100: 5093: 5089: 5088: 5077: 5067: 5065: 5055: 5048: 5038: 5036: 5029: 5025: 5015: 5013: 5008: 5007: 5003: 4993: 4991: 4981: 4977: 4967: 4965: 4958: 4954: 4903: 4899: 4854: 4847: 4802: 4798: 4753: 4749: 4739: 4737: 4725: 4721: 4711: 4709: 4697: 4693: 4678: 4674: 4665: 4663: 4645: 4641: 4596: 4592: 4582: 4580: 4565: 4564: 4560: 4550: 4548: 4536: 4532: 4493: 4489: 4458: 4454: 4445: 4443: 4425: 4421: 4376: 4367: 4320: 4316: 4277: 4268: 4227:(26): 11657–8. 4213: 4206: 4169: 4165: 4128: 4124: 4114: 4112: 4105: 4101: 4072: 4068: 4015: 4011: 3964: 3957: 3916:(26): 12034–9. 3902: 3898: 3843: 3839: 3800:(7245): 442–5. 3786: 3777: 3740: 3736: 3699: 3695: 3655: 3651: 3641: 3639: 3601: 3597: 3544: 3540: 3501: 3494: 3465:(10): 2301–16. 3455: 3444: 3421:10.1038/nrg3686 3405: 3401: 3362: 3351: 3298: 3294: 3241: 3237: 3195:(7603): 420–4. 3181: 3174: 3137: 3133: 3078: 3074: 3064: 3062: 3047: 3043: 2988: 2984: 2939: 2935: 2890: 2886: 2857: 2853: 2830:10.1038/nrg2842 2814: 2803: 2748: 2744: 2715:(12): 1427–32. 2709:Nature Medicine 2705: 2701: 2662: 2655: 2608: 2604: 2559: 2555: 2547: 2545: 2538: 2537: 2533: 2501: 2497: 2460: 2456: 2411: 2407: 2362: 2353: 2308: 2301: 2262: 2258: 2221: 2217: 2207: 2205: 2200: 2199: 2192: 2155: 2148: 2141: 2119: 2115: 2106: 2104: 2101:Broad Institute 2095: 2094: 2090: 2035:(6563): 57–65. 2020: 2016: 2007: 2005: 1996: 1995: 1991: 1982: 1980: 1970: 1961: 1932:(7): e1900032. 1922: 1918: 1908: 1906: 1872: 1868: 1858: 1856: 1845: 1841: 1831: 1829: 1825: 1819: 1804: 1781:(6–8): 629–37. 1767: 1763: 1738: 1716: 1712: 1667: 1663: 1652: 1648: 1613: 1612: 1608: 1565: 1556: 1505: 1501: 1470: 1466: 1461: 1418: 1410:Jennifer Doudna 1404:was awarded to 1391: 1340: 1300:designer babies 1284: 1278: 1231: 1207:Dolly the sheep 1156: 1144:Hunter syndrome 1115:, and to evade 1097: 1092: 1083: 806: 774: 702: 671:electroporation 654: 629: 620: 611: 591: 585: 546: 470: 419: 413:/Cas9) system. 390: 350: 345: 328:Cre recombinase 312: 300:Oliver Smithies 288:gene expression 286:genes or alter 276:transgenic mice 260: 255: 223: 89: 38:, is a type of 17: 12: 11: 5: 5562: 5552: 5551: 5549:Genome editing 5537: 5536: 5526:yourgenome.org 5518: 5497: 5479: 5463: 5445:(4): 752–772. 5432: 5429: 5423: 5422: 5396: 5370: 5344: 5295: 5269: 5247: 5222: 5197: 5164: 5139: 5114: 5075: 5046: 5023: 5001: 4975: 4952: 4897: 4845: 4796: 4747: 4719: 4691: 4672: 4639: 4590: 4558: 4530: 4487: 4452: 4419: 4390:(22): 1463–8. 4365: 4314: 4287:(7): 1417–27. 4266: 4204: 4163: 4122: 4099: 4066: 4009: 3955: 3896: 3837: 3775: 3754:(1–2): 27–31. 3734: 3693: 3666:(4): 465–480. 3649: 3595: 3538: 3505:Nature Methods 3492: 3442: 3399: 3372:(9): 933–941. 3349: 3292: 3235: 3172: 3131: 3072: 3041: 2982: 2953:(7): 397–405. 2933: 2884: 2851: 2801: 2762:(3): 1156–60. 2742: 2699: 2666:Nature Methods 2653: 2602: 2573:(16): 5601–8. 2553: 2531: 2495: 2474:(4): 895–905. 2468:Molecular Cell 2454: 2425:(17): 3870–9. 2405: 2351: 2316:Nature Methods 2299: 2256: 2215: 2190: 2146: 2139: 2113: 2088: 2014: 1989: 1978:Science | AAAS 1959: 1916: 1866: 1839: 1802: 1761: 1736: 1710: 1661: 1646: 1619:Nature Methods 1606: 1554: 1519:(8): 600–611. 1499: 1480:(4): 752–772. 1463: 1462: 1460: 1457: 1456: 1455: 1449: 1444: 1439: 1434: 1429: 1424: 1417: 1414: 1390: 1387: 1339: 1336: 1308:sense of smell 1288:transhumanists 1280:Main article: 1277: 1274: 1230: 1227: 1155: 1152: 1096: 1093: 1091: 1088: 1085: 1084: 1082: 1081: 1074: 1067: 1059: 1056: 1055: 1054: 1053: 1048: 1043: 1035: 1034: 1030: 1029: 1028: 1027: 1022: 1017: 1012: 1007: 999: 998: 992: 991: 990: 989: 984: 977: 972: 964: 963: 957: 956: 955: 954: 949: 944: 936: 935: 933:Genome editing 929: 928: 927: 926: 921: 916: 908: 907: 901: 900: 894: 893: 805: 802: 773: 770: 769: 768: 765: 759: 754: 748: 742: 739: 701: 698: 653: 650: 628: 625: 619: 616: 610: 607: 587:Main article: 584: 581: 545: 542: 500:FokI nucleases 469: 466: 418: 415: 389: 386: 349: 346: 344: 341: 311: 308: 292:Mario Capecchi 264:gene targeting 259: 256: 254: 253:Gene targeting 251: 238:specific sites 222: 219: 211:European Union 95:Nature Methods 88: 85: 28:Genome editing 15: 9: 6: 4: 3: 2: 5561: 5550: 5547: 5546: 5544: 5527: 5523: 5519: 5509: 5508: 5503: 5498: 5488: 5484: 5480: 5476: 5472: 5468: 5464: 5460: 5456: 5452: 5448: 5444: 5440: 5435: 5434: 5428: 5410: 5406: 5400: 5385: 5381: 5374: 5359: 5355: 5348: 5340: 5336: 5331: 5326: 5322: 5318: 5314: 5310: 5306: 5299: 5283: 5276: 5274: 5258: 5251: 5233: 5226: 5211: 5210:New York Post 5207: 5201: 5187: 5183: 5179: 5175: 5168: 5153: 5149: 5143: 5128: 5124: 5118: 5099: 5092: 5086: 5084: 5082: 5080: 5064: 5060: 5053: 5051: 5034: 5027: 5011: 5005: 4990: 4986: 4983:Jorgensen E. 4979: 4963: 4956: 4948: 4944: 4940: 4936: 4932: 4928: 4924: 4920: 4917:(2): 97–101. 4916: 4912: 4908: 4901: 4893: 4889: 4884: 4879: 4875: 4871: 4867: 4863: 4859: 4852: 4850: 4841: 4837: 4832: 4827: 4823: 4819: 4816:(3): 136–43. 4815: 4811: 4807: 4800: 4792: 4788: 4783: 4778: 4774: 4770: 4766: 4762: 4758: 4751: 4736: 4735: 4730: 4723: 4708: 4707: 4702: 4695: 4687: 4683: 4676: 4662: 4658: 4654: 4653:The Telegraph 4650: 4643: 4635: 4631: 4626: 4621: 4617: 4613: 4609: 4605: 4601: 4594: 4578: 4574: 4573: 4568: 4562: 4547: 4546: 4541: 4534: 4526: 4522: 4518: 4514: 4510: 4506: 4502: 4498: 4491: 4483: 4479: 4475: 4471: 4468:(6262): 731. 4467: 4463: 4456: 4442: 4438: 4434: 4430: 4423: 4415: 4411: 4406: 4401: 4397: 4393: 4389: 4385: 4381: 4374: 4372: 4370: 4361: 4357: 4352: 4347: 4342: 4337: 4333: 4329: 4325: 4318: 4310: 4306: 4302: 4298: 4294: 4290: 4286: 4282: 4275: 4273: 4271: 4262: 4258: 4253: 4248: 4243: 4238: 4234: 4230: 4226: 4222: 4218: 4211: 4209: 4200: 4196: 4191: 4186: 4183:(1): 169–76. 4182: 4178: 4174: 4167: 4159: 4155: 4150: 4145: 4142:(7): 934–40. 4141: 4137: 4133: 4126: 4110: 4103: 4094: 4089: 4085: 4081: 4077: 4070: 4062: 4058: 4053: 4048: 4044: 4040: 4036: 4032: 4028: 4026: 4022: 4013: 4005: 4001: 3997: 3993: 3989: 3985: 3981: 3977: 3973: 3969: 3962: 3960: 3951: 3947: 3942: 3937: 3932: 3927: 3923: 3919: 3915: 3911: 3907: 3900: 3892: 3888: 3883: 3878: 3873: 3868: 3864: 3860: 3856: 3852: 3848: 3841: 3833: 3829: 3824: 3819: 3815: 3811: 3807: 3803: 3799: 3795: 3791: 3784: 3782: 3780: 3771: 3767: 3762: 3757: 3753: 3749: 3745: 3738: 3730: 3726: 3721: 3716: 3712: 3708: 3704: 3697: 3689: 3685: 3681: 3677: 3673: 3669: 3665: 3661: 3653: 3638: 3634: 3630: 3626: 3622: 3618: 3614: 3610: 3606: 3599: 3591: 3587: 3582: 3577: 3573: 3569: 3565: 3561: 3557: 3553: 3549: 3542: 3534: 3530: 3526: 3522: 3518: 3514: 3510: 3506: 3499: 3497: 3488: 3484: 3480: 3476: 3472: 3468: 3464: 3460: 3453: 3451: 3449: 3447: 3438: 3434: 3430: 3426: 3422: 3418: 3415:(5): 321–34. 3414: 3410: 3403: 3395: 3391: 3387: 3383: 3379: 3375: 3371: 3367: 3360: 3358: 3356: 3354: 3345: 3341: 3336: 3331: 3327: 3323: 3319: 3315: 3311: 3307: 3303: 3296: 3288: 3284: 3280: 3276: 3272: 3268: 3263: 3258: 3254: 3250: 3246: 3239: 3233: 3228: 3224: 3219: 3214: 3210: 3206: 3202: 3198: 3194: 3190: 3186: 3179: 3177: 3168: 3164: 3159: 3154: 3150: 3146: 3142: 3135: 3127: 3123: 3118: 3113: 3108: 3103: 3099: 3095: 3091: 3087: 3083: 3076: 3060: 3056: 3052: 3045: 3037: 3033: 3028: 3023: 3018: 3013: 3009: 3005: 3002:(7): e68464. 3001: 2997: 2993: 2986: 2978: 2974: 2969: 2964: 2960: 2956: 2952: 2948: 2944: 2937: 2929: 2925: 2920: 2915: 2911: 2907: 2904:(8): 839–47. 2903: 2899: 2895: 2888: 2879: 2874: 2870: 2866: 2862: 2855: 2847: 2843: 2839: 2835: 2831: 2827: 2824:(9): 636–46. 2823: 2819: 2812: 2810: 2808: 2806: 2797: 2793: 2788: 2783: 2778: 2773: 2769: 2765: 2761: 2757: 2753: 2746: 2738: 2734: 2730: 2726: 2722: 2718: 2714: 2710: 2703: 2695: 2691: 2687: 2683: 2679: 2675: 2671: 2667: 2660: 2658: 2649: 2645: 2641: 2637: 2633: 2629: 2625: 2621: 2617: 2613: 2606: 2598: 2594: 2589: 2584: 2580: 2576: 2572: 2568: 2564: 2557: 2543: 2542: 2535: 2527: 2523: 2519: 2515: 2512:(3): 443–58. 2511: 2507: 2499: 2491: 2487: 2482: 2477: 2473: 2469: 2465: 2458: 2450: 2446: 2441: 2436: 2432: 2428: 2424: 2420: 2416: 2409: 2401: 2397: 2392: 2387: 2383: 2379: 2375: 2371: 2367: 2360: 2358: 2356: 2347: 2343: 2339: 2335: 2330: 2325: 2321: 2317: 2313: 2306: 2304: 2295: 2291: 2287: 2283: 2279: 2275: 2271: 2267: 2260: 2252: 2248: 2243: 2238: 2234: 2230: 2226: 2219: 2203: 2197: 2195: 2186: 2182: 2177: 2172: 2168: 2164: 2160: 2153: 2151: 2142: 2136: 2131: 2130: 2124: 2117: 2102: 2098: 2092: 2084: 2080: 2076: 2072: 2067: 2062: 2058: 2054: 2050: 2046: 2042: 2038: 2034: 2030: 2026: 2018: 2003: 1999: 1993: 1979: 1975: 1968: 1966: 1964: 1955: 1951: 1947: 1943: 1939: 1935: 1931: 1927: 1920: 1905: 1901: 1897: 1893: 1889: 1885: 1881: 1877: 1870: 1854: 1850: 1843: 1824: 1817: 1815: 1813: 1811: 1809: 1807: 1798: 1794: 1789: 1784: 1780: 1776: 1772: 1765: 1757: 1753: 1748: 1743: 1739: 1737:9780124047426 1733: 1729: 1725: 1721: 1714: 1706: 1702: 1697: 1692: 1688: 1684: 1680: 1676: 1672: 1665: 1657: 1650: 1642: 1638: 1633: 1628: 1624: 1620: 1616: 1610: 1602: 1598: 1594: 1590: 1586: 1582: 1578: 1574: 1570: 1563: 1561: 1559: 1550: 1546: 1542: 1538: 1534: 1530: 1526: 1522: 1518: 1514: 1510: 1503: 1495: 1491: 1487: 1483: 1479: 1475: 1468: 1464: 1453: 1450: 1448: 1445: 1443: 1440: 1438: 1437:Prime editing 1435: 1433: 1430: 1428: 1425: 1423: 1420: 1419: 1413: 1411: 1407: 1403: 1400:In 2020, the 1398: 1396: 1393:In 2007, the 1386: 1384: 1380: 1379:bioterrorists 1377:by potential 1376: 1372: 1368: 1364: 1360: 1355: 1353: 1349: 1345: 1335: 1332: 1328: 1325:The American 1323: 1321: 1317: 1313: 1312:George Church 1309: 1305: 1301: 1297: 1293: 1289: 1283: 1273: 1271: 1267: 1262: 1258: 1254: 1250: 1247: 1243: 1240: 1235: 1226: 1224: 1223:Lulu and Nana 1220: 1216: 1212: 1208: 1204: 1200: 1195: 1193: 1189: 1188:Lulu and Nana 1185: 1181: 1177: 1171: 1167: 1165: 1161: 1151: 1149: 1145: 1141: 1137: 1133: 1129: 1124: 1120: 1118: 1114: 1110: 1105: 1102: 1080: 1075: 1073: 1068: 1066: 1061: 1060: 1058: 1057: 1052: 1049: 1047: 1044: 1042: 1039: 1038: 1037: 1036: 1032: 1031: 1026: 1023: 1021: 1018: 1016: 1013: 1011: 1008: 1006: 1003: 1002: 1001: 1000: 997: 994: 993: 988: 985: 983: 982: 978: 976: 973: 971: 968: 967: 966: 965: 962: 959: 958: 953: 950: 948: 945: 943: 940: 939: 938: 937: 934: 931: 930: 925: 922: 920: 917: 915: 912: 911: 910: 909: 906: 903: 902: 899: 896: 895: 891: 887: 886: 883: 881: 880:Agrobacterium 877: 873: 869: 865: 864:Agrobacterium 860: 858: 852: 848: 846: 844: 839: 835: 831: 827: 823: 819: 810: 801: 797: 794: 790: 786: 784: 779: 766: 764:gene labeling 763: 760: 758: 755: 753: 749: 747: 743: 740: 737: 736: 735: 732: 729: 724: 720: 716: 706: 697: 694: 690: 682: 681: 674: 672: 666: 658: 649: 646: 641: 637: 633: 624: 615: 606: 604: 599: 595: 590: 580: 578: 573: 571: 566: 562: 561:TAL effectors 558: 550: 541: 539: 535: 531: 527: 523: 519: 517: 511: 509: 503: 501: 496: 491: 487: 485: 481: 478: 474: 465: 463: 458: 456: 450: 447: 443: 437: 435: 431: 427: 423: 422:Meganucleases 417:Meganucleases 414: 412: 408: 404: 394: 385: 382: 378: 374: 370: 366: 358: 354: 340: 338: 334: 329: 325: 321: 317: 307: 305: 301: 297: 293: 289: 285: 281: 277: 273: 269: 265: 250: 248: 244: 239: 235: 231: 227: 218: 216: 212: 208: 203: 199: 197: 193: 190: 185: 183: 179: 175: 171: 167: 163: 158: 156: 152: 148: 144: 140: 136: 133: 128: 126: 122: 118: 114: 110: 109:meganucleases 105: 103: 102: 97: 96: 84: 82: 78: 74: 70: 66: 62: 58: 53: 49: 45: 41: 37: 33: 29: 21: 5529:. Retrieved 5525: 5511:. Retrieved 5505: 5490:. Retrieved 5486: 5474: 5470: 5442: 5438: 5426: 5413:. Retrieved 5399: 5387:. Retrieved 5384:The Guardian 5383: 5373: 5361:. Retrieved 5357: 5347: 5315:(1): 18–24. 5312: 5309:EMBO Reports 5308: 5298: 5286:. Retrieved 5280:Regalado A. 5260:. Retrieved 5250: 5238:. Retrieved 5225: 5214:. Retrieved 5209: 5200: 5189:. Retrieved 5177: 5167: 5155:. Retrieved 5151: 5142: 5130:. Retrieved 5126: 5117: 5105:. Retrieved 5098:the original 5066:. Retrieved 5063:The Guardian 5062: 5037:. Retrieved 5031:Regalado A. 5026: 5014:. Retrieved 5004: 4992:. Retrieved 4988: 4978: 4966:. Retrieved 4955: 4914: 4910: 4900: 4865: 4861: 4813: 4809: 4799: 4764: 4760: 4750: 4738:. Retrieved 4732: 4722: 4710:. Retrieved 4704: 4694: 4685: 4675: 4664:. Retrieved 4652: 4642: 4610:(1): 78–83. 4607: 4603: 4593: 4581:. Retrieved 4570: 4561: 4549:. Retrieved 4543: 4533: 4500: 4496: 4490: 4465: 4461: 4455: 4444:. Retrieved 4432: 4422: 4387: 4384:Gene Therapy 4383: 4331: 4327: 4317: 4284: 4280: 4224: 4220: 4180: 4176: 4166: 4139: 4135: 4125: 4113:. Retrieved 4102: 4083: 4079: 4069: 4034: 4030: 4024: 4020: 4012: 3971: 3967: 3913: 3909: 3899: 3854: 3850: 3840: 3797: 3793: 3751: 3747: 3737: 3710: 3706: 3696: 3663: 3659: 3652: 3640:. Retrieved 3612: 3608: 3598: 3555: 3551: 3541: 3511:(1): 28–31. 3508: 3504: 3462: 3458: 3412: 3408: 3402: 3369: 3365: 3309: 3305: 3295: 3252: 3249:Trends Genet 3248: 3238: 3192: 3188: 3148: 3144: 3134: 3089: 3085: 3075: 3063:. Retrieved 3059:the original 3054: 3044: 2999: 2995: 2985: 2950: 2946: 2936: 2901: 2897: 2887: 2868: 2864: 2854: 2821: 2817: 2759: 2755: 2745: 2712: 2708: 2702: 2669: 2665: 2615: 2611: 2605: 2570: 2566: 2556: 2546:, retrieved 2544:, 2006-10-18 2540: 2534: 2509: 2505: 2498: 2471: 2467: 2457: 2422: 2418: 2408: 2376:(22): e149. 2373: 2369: 2319: 2315: 2272:(1): 49–95. 2269: 2265: 2259: 2235:(6): 224–8. 2232: 2228: 2218: 2208:December 15, 2206:. Retrieved 2166: 2162: 2128: 2116: 2105:. Retrieved 2103:. 2021-09-09 2100: 2091: 2032: 2028: 2017: 2006:. Retrieved 2002:ScienceAlert 2001: 1992: 1981:. Retrieved 1977: 1929: 1925: 1919: 1907:. Retrieved 1879: 1869: 1857:. Retrieved 1852: 1842: 1832:November 30, 1830:. Retrieved 1778: 1774: 1764: 1719: 1713: 1678: 1674: 1664: 1649: 1622: 1618: 1609: 1579:(4): 341–4. 1576: 1572: 1516: 1512: 1502: 1477: 1473: 1467: 1399: 1392: 1356: 1343: 1342:In the 2016 1341: 1324: 1304:night vision 1285: 1263: 1259: 1255: 1251: 1248: 1244: 1239:Dana Carroll 1236: 1232: 1196: 1172: 1168: 1163: 1157: 1125: 1121: 1106: 1101:gene therapy 1098: 1095:Gene therapy 1033:Other topics 979: 947:Gene therapy 932: 889: 879: 863: 861: 853: 849: 842: 829: 825: 821: 818:Meganuclease 815: 798: 791: 787: 782: 777: 775: 741:Gene therapy 733: 711: 700:Applications 692: 678: 675: 667: 663: 642: 638: 634: 630: 621: 612: 592: 574: 564: 555: 538:glioblastoma 534:immune cells 520: 512: 504: 492: 488: 475: 471: 459: 454: 451: 438: 426:endonuclease 420: 399: 362: 313: 296:Martin Evans 266:) relied on 261: 243:gene therapy 224: 204: 200: 186: 178:human genome 159: 129: 106: 99: 93: 90: 36:gene editing 35: 31: 27: 26: 5389:27 December 5363:27 December 5288:26 December 5262:26 December 5240:26 December 5107:27 December 5068:26 December 5039:26 December 5016:26 December 4994:26 December 4968:26 December 4706:EurekAlert! 4503:: 323–327. 3558:(1): 7753. 2672:(1): 23–6. 1859:10 February 1427:RNA editing 1422:CRISPR/Cpf1 1389:Nobel prize 1160:gene drives 1113:Alemtuzumab 1025:Mirror life 996:Xenobiology 876:Ti plasmids 838:CRISPR/Cas9 477:Zinc finger 442:mutagenesis 371:(NHEJ) and 280:knocked out 215:transposons 157:('edits'). 5531:2018-04-13 5513:2016-02-11 5492:2019-02-21 5216:2017-02-17 5191:2017-02-17 4740:24 January 4712:24 January 4666:2018-08-12 4583:7 February 4551:7 February 4446:2015-11-30 3151:(4): 296. 3065:2 November 2548:2018-08-11 2107:2021-10-04 2008:2020-02-09 1983:2021-05-27 1855:. NIHvcast 1681:(1): 641. 1459:References 1363:biohackers 1266:Gene drive 1219:He Jiankui 1176:He Jiankui 1164:A. gambiae 1099:The ideal 762:Endogenous 752:stem cells 530:stem cells 381:homologous 221:Background 166:He Jiankui 149:(NHEJ) or 132:engineered 5471:Bioethics 5459:233713026 5415:7 October 5186:0362-4331 4939:1469-1795 4661:0307-1235 4441:0362-4331 4037:(1): 46. 3637:197665984 3326:2162-2531 3287:236934922 3271:0168-9525 2865:Mol. Ther 2846:205484701 2322:(1): 27. 2083:238237947 2057:0036-8075 1954:155086967 1926:BioEssays 1904:182604140 1533:0168-9525 1494:233713026 1316:for sleep 1192:mosaicism 987:Protocell 781:available 744:Creating 715:zebrafish 326:systems. 205:In 2021, 155:mutations 135:nucleases 79:(HDR) or 42:in which 5543:Category 5409:Archived 5339:20010799 5127:Futurism 4947:27633404 4892:24906146 4840:27667185 4791:32243835 4634:26641531 4525:24192441 4517:27646312 4482:26564829 4414:18784746 4360:28696921 4301:27114166 4261:20554917 4199:25846201 4158:24851712 4115:16 April 4061:30729184 3996:19404259 3950:20508151 3891:20508152 3832:19404258 3770:21047873 3729:29729430 3688:22247493 3680:16906447 3642:29 April 3629:31321691 3590:29773834 3525:22205513 3487:16447825 3479:25188632 3429:24690881 3394:21543486 3386:27606440 3344:30965277 3279:34353635 3232:SharedIt 3227:27096365 3167:28303022 3036:23869221 2996:PLOS ONE 2977:23664777 2928:20601939 2838:20717154 2737:23318821 2729:12415262 2694:37050234 2686:22312637 2640:18987743 2597:20435674 2526:16310802 2490:12419232 2449:12202772 2400:17130168 2346:26924628 2338:22312638 2294:27841011 2286:16336743 2185:26397828 2075:34591643 1946:31090950 1896:32424191 1797:24166445 1756:23084873 1705:23340847 1641:22312634 1549:49269023 1541:29908711 1416:See also 1383:smallpox 1371:mousepox 1320:learning 1090:Research 919:BioBrick 826:Zea mays 778:in vitro 685:1-deoxy- 643:Because 603:plasmids 430:proteins 320:Cre-LoxP 284:knock in 145:through 143:repaired 115:(ZFNs), 83:(NHEJ). 5477:. 2020. 5330:2816623 5157:25 July 5132:25 July 4919:Bibcode 4883:4343198 4831:5035944 4782:7264426 4734:Gizmodo 4625:4913862 4545:AP News 4462:Science 4405:2747807 4351:5592921 4309:8035222 4252:2900667 4229:Bibcode 4052:6355771 4004:4323298 3976:Bibcode 3941:2900650 3918:Bibcode 3882:2900673 3859:Bibcode 3823:2743854 3802:Bibcode 3713:: 1–6. 3581:5958112 3560:Bibcode 3533:2144013 3437:9373606 3335:6454098 3218:4873371 3197:Bibcode 3126:7545300 3094:Bibcode 3027:3711819 3004:Bibcode 2968:3694601 2919:3080757 2796:8577732 2764:Bibcode 2648:4300643 2620:Bibcode 2588:2938204 2391:1702487 2251:8928227 2066:8929163 2037:Bibcode 2029:Science 1853:YouTube 1747:3683964 1696:3564264 1601:9210810 1593:9555723 1041:Hazards 723:tobacco 594:CRISPRs 343:Process 324:Flp-FRT 207:England 168:of the 101:Science 87:History 59:(DBD), 5457:  5337:  5327:  5184:  4945:  4937:  4890:  4880:  4838:  4828:  4789:  4779:  4659:  4632:  4622:  4523:  4515:  4480:  4439:  4412:  4402:  4358:  4348:  4307:  4299:  4259:  4249:  4197:  4156:  4059:  4049:  4002:  3994:  3968:Nature 3948:  3938:  3889:  3879:  3830:  3820:  3794:Nature 3768:  3727:  3686:  3678:  3635:  3627:  3588:  3578:  3531:  3523:  3485:  3477:  3435:  3427:  3392:  3384:  3342:  3332:  3324:  3285:  3277:  3269:  3225:  3215:  3189:Nature 3165:  3124:  3114:  3034:  3024:  2975:  2965:  2926:  2916:  2844:  2836:  2794:  2784:  2735:  2727:  2692:  2684:  2646:  2638:  2612:Nature 2595:  2585:  2524:  2488:  2447:  2440:137417 2437:  2398:  2388:  2344:  2336:  2292:  2284:  2249:  2183:  2137:  2081:  2073:  2063:  2055:  1952:  1944:  1909:20 May 1902:  1894:  1880:Nature 1795:  1754:  1744:  1734:  1703:  1693:  1639:  1599:  1591:  1547:  1539:  1531:  1492:  1211:Crispr 1199:cloned 942:CRISPR 583:CRISPR 480:motifs 411:CRISPR 377:vector 234:genome 182:CRISPR 121:CRISPR 48:genome 5455:S2CID 5235:(PDF) 5101:(PDF) 5094:(PDF) 4943:S2CID 4521:S2CID 4305:S2CID 4000:S2CID 3684:S2CID 3633:S2CID 3529:S2CID 3483:S2CID 3433:S2CID 3390:S2CID 3283:S2CID 3117:41144 2842:S2CID 2787:40048 2733:S2CID 2690:S2CID 2644:S2CID 2342:S2CID 2290:S2CID 2079:S2CID 1950:S2CID 1900:S2CID 1826:(PDF) 1597:S2CID 1545:S2CID 1490:S2CID 1452:NgAgo 1338:Risks 1286:Many 868:T-DNA 828:. In 719:maize 618:ARCUT 544:TALEN 407:TALEN 172:(see 162:China 34:, or 30:, or 5417:2020 5391:2016 5365:2016 5335:PMID 5290:2016 5264:2016 5242:2016 5182:ISSN 5159:2021 5134:2021 5109:2016 5070:2016 5041:2016 5018:2016 4996:2016 4970:2016 4935:ISSN 4888:PMID 4862:Cell 4836:PMID 4787:PMID 4742:2019 4714:2019 4686:STAT 4657:ISSN 4630:PMID 4585:2019 4553:2019 4513:PMID 4478:PMID 4437:ISSN 4410:PMID 4356:PMID 4297:PMID 4257:PMID 4195:PMID 4154:PMID 4117:2018 4057:PMID 4025:Musa 3992:PMID 3946:PMID 3887:PMID 3828:PMID 3766:PMID 3725:PMID 3676:PMID 3644:2021 3625:PMID 3586:PMID 3521:PMID 3475:PMID 3425:PMID 3382:PMID 3340:PMID 3322:ISSN 3275:PMID 3267:ISSN 3223:PMID 3163:PMID 3122:PMID 3067:2017 3032:PMID 2973:PMID 2924:PMID 2834:PMID 2792:PMID 2725:PMID 2682:PMID 2636:PMID 2593:PMID 2522:PMID 2486:PMID 2445:PMID 2396:PMID 2334:PMID 2282:PMID 2247:PMID 2210:2008 2181:PMID 2135:ISBN 2071:PMID 2053:ISSN 1942:PMID 1911:2019 1892:PMID 1861:2017 1834:2015 1793:PMID 1752:PMID 1732:ISBN 1701:PMID 1637:PMID 1589:PMID 1537:PMID 1529:ISSN 1408:and 1329:and 1306:and 1215:Cas9 1180:CCR5 845:spp. 843:Musa 824:and 721:and 508:FokI 495:FokI 444:and 403:ZFNs 322:and 298:and 187:The 125:Cas9 71:and 69:FokI 5447:doi 5325:PMC 5317:doi 4927:doi 4878:PMC 4870:doi 4866:157 4826:PMC 4818:doi 4777:PMC 4769:doi 4620:PMC 4612:doi 4505:doi 4470:doi 4466:350 4400:PMC 4392:doi 4346:PMC 4336:doi 4289:doi 4247:PMC 4237:doi 4225:107 4185:doi 4144:doi 4088:doi 4047:PMC 4039:doi 3984:doi 3972:459 3936:PMC 3926:doi 3914:107 3877:PMC 3867:doi 3855:107 3818:PMC 3810:doi 3798:459 3756:doi 3715:doi 3668:doi 3617:doi 3576:PMC 3568:doi 3513:doi 3467:doi 3417:doi 3374:doi 3330:PMC 3314:doi 3257:doi 3213:PMC 3205:doi 3193:533 3153:doi 3112:PMC 3102:doi 3022:PMC 3012:doi 2963:PMC 2955:doi 2914:PMC 2906:doi 2873:doi 2826:doi 2782:PMC 2772:doi 2717:doi 2674:doi 2628:doi 2616:456 2583:PMC 2575:doi 2514:doi 2510:355 2476:doi 2435:PMC 2427:doi 2386:PMC 2378:doi 2324:doi 2274:doi 2237:doi 2171:doi 2061:PMC 2045:doi 2033:374 1934:doi 1884:doi 1783:doi 1742:PMC 1724:doi 1691:PMC 1683:doi 1627:doi 1581:doi 1521:doi 1482:doi 1184:HIV 1140:DNA 230:DNA 73:Cas 44:DNA 5545:: 5524:. 5504:. 5485:. 5475:34 5473:. 5469:. 5453:. 5443:39 5441:. 5382:. 5356:. 5333:. 5323:. 5313:11 5311:. 5307:. 5272:^ 5208:. 5180:. 5176:. 5150:. 5125:. 5078:^ 5061:. 5049:^ 4987:. 4941:. 4933:. 4925:. 4915:19 4913:. 4909:. 4886:. 4876:. 4864:. 4860:. 4848:^ 4834:. 4824:. 4812:. 4808:. 4785:. 4775:. 4765:28 4763:. 4759:. 4731:. 4703:. 4684:. 4655:. 4651:. 4628:. 4618:. 4608:34 4606:. 4602:. 4575:. 4569:. 4542:. 4519:. 4511:. 4501:71 4499:. 4476:. 4464:. 4435:. 4431:. 4408:. 4398:. 4388:15 4386:. 4382:. 4368:^ 4354:. 4344:. 4330:. 4328:G3 4326:. 4303:. 4295:. 4285:35 4283:. 4269:^ 4255:. 4245:. 4235:. 4223:. 4219:. 4207:^ 4193:. 4181:14 4179:. 4175:. 4152:. 4140:12 4138:. 4134:. 4086:. 4084:10 4082:. 4078:. 4055:. 4045:. 4033:. 4029:. 3998:. 3990:. 3982:. 3970:. 3958:^ 3944:. 3934:. 3924:. 3912:. 3908:. 3885:. 3875:. 3865:. 3853:. 3849:. 3826:. 3816:. 3808:. 3796:. 3792:. 3778:^ 3764:. 3752:24 3750:. 3746:. 3723:. 3711:52 3709:. 3705:. 3682:. 3674:. 3664:15 3662:. 3631:. 3623:. 3613:28 3611:. 3607:. 3584:. 3574:. 3566:. 3554:. 3550:. 3527:. 3519:. 3507:. 3495:^ 3481:. 3473:. 3461:. 3445:^ 3431:. 3423:. 3413:15 3411:. 3388:. 3380:. 3370:34 3368:. 3352:^ 3338:. 3328:. 3320:. 3310:16 3308:. 3304:. 3281:. 3273:. 3265:. 3253:37 3251:. 3247:. 3221:. 3211:. 3203:. 3191:. 3187:. 3175:^ 3161:. 3149:16 3147:. 3143:. 3120:. 3110:. 3100:. 3090:92 3088:. 3084:. 3053:. 3030:. 3020:. 3010:. 2998:. 2994:. 2971:. 2961:. 2951:31 2949:. 2945:. 2922:. 2912:. 2902:28 2900:. 2896:. 2869:16 2867:. 2863:. 2840:. 2832:. 2822:11 2820:. 2804:^ 2790:. 2780:. 2770:. 2760:93 2758:. 2754:. 2731:. 2723:. 2711:. 2688:. 2680:. 2668:. 2656:^ 2642:. 2634:. 2626:. 2614:. 2591:. 2581:. 2571:38 2569:. 2565:. 2520:. 2508:. 2484:. 2472:10 2470:. 2466:. 2443:. 2433:. 2423:30 2421:. 2417:. 2394:. 2384:. 2374:34 2372:. 2368:. 2354:^ 2340:. 2332:. 2318:. 2314:. 2302:^ 2288:. 2280:. 2270:38 2268:. 2245:. 2233:12 2231:. 2227:. 2193:^ 2179:. 2167:87 2165:. 2161:. 2149:^ 2125:. 2099:. 2077:. 2069:. 2059:. 2051:. 2043:. 2031:. 2027:. 2000:. 1976:. 1962:^ 1948:. 1940:. 1930:41 1928:. 1898:. 1890:. 1882:. 1878:. 1851:. 1805:^ 1791:. 1779:57 1777:. 1773:. 1750:. 1740:. 1730:. 1699:. 1689:. 1677:. 1673:. 1635:. 1621:. 1617:. 1595:. 1587:. 1577:16 1575:. 1571:. 1557:^ 1543:. 1535:. 1527:. 1517:34 1515:. 1511:. 1488:. 1478:39 1476:. 1310:. 717:, 436:. 339:. 306:. 294:, 249:. 111:, 5534:. 5516:. 5495:. 5461:. 5449:: 5419:. 5393:. 5367:. 5341:. 5319:: 5292:. 5266:. 5244:. 5219:. 5194:. 5161:. 5136:. 5111:. 5072:. 5043:. 5020:. 4998:. 4972:. 4949:. 4929:: 4921:: 4894:. 4872:: 4842:. 4820:: 4814:9 4793:. 4771:: 4744:. 4716:. 4688:. 4669:. 4636:. 4614:: 4587:. 4555:. 4527:. 4507:: 4484:. 4472:: 4449:. 4416:. 4394:: 4362:. 4338:: 4332:7 4311:. 4291:: 4263:. 4239:: 4231:: 4201:. 4187:: 4160:. 4146:: 4119:. 4096:. 4090:: 4063:. 4041:: 4035:2 4006:. 3986:: 3978:: 3952:. 3928:: 3920:: 3893:. 3869:: 3861:: 3834:. 3812:: 3804:: 3772:. 3758:: 3731:. 3717:: 3690:. 3670:: 3646:. 3619:: 3592:. 3570:: 3562:: 3556:8 3535:. 3515:: 3509:9 3489:. 3469:: 3463:9 3439:. 3419:: 3396:. 3376:: 3346:. 3316:: 3289:. 3259:: 3229:. 3207:: 3199:: 3169:. 3155:: 3128:. 3104:: 3096:: 3069:. 3038:. 3014:: 3006:: 3000:8 2979:. 2957:: 2930:. 2908:: 2881:. 2875:: 2848:. 2828:: 2798:. 2774:: 2766:: 2739:. 2719:: 2713:8 2696:. 2676:: 2670:9 2650:. 2630:: 2622:: 2599:. 2577:: 2528:. 2516:: 2492:. 2478:: 2451:. 2429:: 2402:. 2380:: 2348:. 2326:: 2320:9 2296:. 2276:: 2253:. 2239:: 2212:. 2187:. 2173:: 2143:. 2110:. 2085:. 2047:: 2039:: 2011:. 1986:. 1956:. 1936:: 1913:. 1886:: 1863:. 1836:. 1799:. 1785:: 1758:. 1726:: 1707:. 1685:: 1679:9 1658:. 1643:. 1629:: 1623:9 1603:. 1583:: 1551:. 1523:: 1496:. 1484:: 1213:- 1078:e 1071:t 1064:v 783:. 687:D 123:/ 67:(

Index


genetic engineering
DNA
genome
genetic engineering techniques
DNA-binding domain
double-strand breaks
restriction endonucleases
FokI
Cas
homology-directed recombination
non-homologous end joining
Nature Methods
Science
meganucleases
zinc finger nucleases
transcription activator-like effector-based nucleases
CRISPR
Cas9
engineered
nucleases
double-strand breaks
repaired
nonhomologous end-joining
homologous recombination
mutations
China
He Jiankui
first gene-edited humans
Lulu and Nana controversy

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.